| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | NID2 VLDLR STAB2 FBN1 FBN2 MEGF6 MEGF8 ENPP1 JAG1 GNPTAB LRP1 LTBP1 LTBP2 PLSCR2 ITGB1 CDH2 LTBP4 CDH7 PLSCR1 FBN3 NOTCH1 ADGRL4 | 4.96e-15 | 749 | 70 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | NID2 FBN1 FBN2 SBSPON LAMA4 LAMB1 LTBP1 LTBP2 LTBP4 MUC5AC FBN3 | 5.13e-11 | 188 | 70 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.94e-09 | 16 | 70 | 5 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 8.92e-09 | 21 | 70 | 5 | GO:0030228 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.90e-08 | 85 | 70 | 7 | GO:0038024 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 2.29e-06 | 27 | 70 | 4 | GO:0005044 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 5.72e-06 | 73 | 70 | 5 | GO:0050840 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 1.15e-05 | 13 | 70 | 3 | GO:0005024 | |
| GeneOntologyMolecularFunction | lead ion binding | 3.63e-05 | 3 | 70 | 2 | GO:0032791 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 4.51e-05 | 20 | 70 | 3 | GO:0004675 | |
| GeneOntologyMolecularFunction | structural molecule activity | NID2 FBN1 FBN2 SBSPON JAG1 LAMA4 LAMB1 LTBP1 LTBP2 LTBP4 MUC5AC FBN3 | 5.65e-05 | 891 | 70 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 1.01e-04 | 26 | 70 | 3 | GO:0050431 | |
| GeneOntologyMolecularFunction | microfibril binding | 1.80e-04 | 6 | 70 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | cytokine binding | 2.26e-04 | 157 | 70 | 5 | GO:0019955 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.26e-04 | 85 | 70 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 2.36e-04 | 599 | 70 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 2.49e-04 | 35 | 70 | 3 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 2.49e-04 | 35 | 70 | 3 | GO:0071814 | |
| GeneOntologyMolecularFunction | mercury ion binding | 3.35e-04 | 8 | 70 | 2 | GO:0045340 | |
| GeneOntologyMolecularFunction | integrin binding | 3.73e-04 | 175 | 70 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity | 4.29e-04 | 9 | 70 | 2 | GO:0043878 | |
| GeneOntologyMolecularFunction | CD4 receptor binding | 6.53e-04 | 11 | 70 | 2 | GO:0042609 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 7.82e-04 | 12 | 70 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.07e-03 | 14 | 70 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 1.24e-03 | 15 | 70 | 2 | GO:0004029 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 1.38e-03 | 616 | 70 | 8 | GO:0030545 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 1.59e-03 | 17 | 70 | 2 | GO:0004030 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 1.79e-03 | 18 | 70 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.20e-03 | 156 | 70 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.21e-03 | 20 | 70 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 2.92e-03 | 23 | 70 | 2 | GO:0017128 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 3.01e-03 | 547 | 70 | 7 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 3.23e-03 | 554 | 70 | 7 | GO:0030546 | |
| GeneOntologyMolecularFunction | virus receptor activity | 3.32e-03 | 85 | 70 | 3 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 3.43e-03 | 86 | 70 | 3 | GO:0140272 | |
| GeneOntologyMolecularFunction | protease binding | 3.76e-03 | 181 | 70 | 4 | GO:0002020 | |
| GeneOntologyMolecularFunction | Notch binding | 4.02e-03 | 27 | 70 | 2 | GO:0005112 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | FBN1 FBN2 MEGF8 UBE3A ENPP1 LRP1 TRIM71 SHISA2 LTBP1 LTBP2 ACVR1 ITGB1 LTBP4 NOTCH1 SORL1 | 1.29e-07 | 850 | 70 | 15 | GO:0071363 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 1.49e-07 | 4 | 70 | 3 | GO:0035583 | |
| GeneOntologyBiologicalProcess | response to growth factor | FBN1 FBN2 MEGF8 UBE3A ENPP1 LRP1 TRIM71 SHISA2 LTBP1 LTBP2 ACVR1 ITGB1 LTBP4 NOTCH1 SORL1 | 2.10e-07 | 883 | 70 | 15 | GO:0070848 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | FBN1 FBN2 MEGF8 LRP1 LTBP1 LTBP2 ACVR1 ITGB1 LTBP4 NOTCH1 SORL1 | 2.87e-07 | 445 | 70 | 11 | GO:0141091 |
| GeneOntologyBiologicalProcess | aorta development | 3.03e-07 | 80 | 70 | 6 | GO:0035904 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | FBN1 FBN2 MEGF8 CLEC14A ENPP1 LRP1 TRIM71 SHISA2 LTBP1 PRKCQ LTBP2 ACVR1 ITGB1 LTBP4 NOTCH1 EPHA10 SORL1 | 3.17e-07 | 1186 | 70 | 17 | GO:0007167 |
| GeneOntologyBiologicalProcess | cell morphogenesis | VLDLR NTNG2 MEGF8 UBE3A ENPP1 WNT7A LRP1 NTNG1 LAMB1 PRKCQ ITGB1 CDH2 CDH7 ST14 NOTCH1 EPHA10 STC1 | 3.49e-07 | 1194 | 70 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | FBN1 FBN2 MEGF8 LRP1 LTBP1 LTBP2 ACVR1 ITGB1 LTBP4 NOTCH1 SORL1 | 6.32e-07 | 482 | 70 | 11 | GO:0007178 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | NTNG2 FBN2 LRIG1 MEGF8 NSD2 ENPP1 WNT7A JAG1 WNT8B NTNG1 LAMB1 ACVR1 LY6E CDH2 MEGF11 NOTCH1 STC1 | 8.17e-07 | 1269 | 70 | 17 | GO:0009887 |
| GeneOntologyBiologicalProcess | circulatory system development | HDAC3 STAB2 FBN1 MEGF8 NSD2 CLEC14A ENPP1 WNT7A JAG1 LRP1 LAMA4 LTBP1 ACVR1 TNFRSF1A LY6E ITGB1 CDH2 NOTCH1 | 1.01e-06 | 1442 | 70 | 18 | GO:0072359 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | VLDLR NTNG2 MEGF8 UBE3A WNT7A LRP1 NTNG1 LAMB1 PRKCQ ITGB1 CDH2 NOTCH1 EPHA10 | 1.19e-06 | 748 | 70 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | heart development | HDAC3 FBN1 MEGF8 NSD2 ENPP1 JAG1 LRP1 LTBP1 ACVR1 TNFRSF1A LY6E ITGB1 NOTCH1 | 1.36e-06 | 757 | 70 | 13 | GO:0007507 |
| GeneOntologyBiologicalProcess | axon development | NTNG2 MEGF8 ENPP1 WNT7A LRP1 NTNG1 LAMB1 PRKCQ ITGB1 CDH2 NOTCH1 EPHA10 | 1.52e-06 | 642 | 70 | 12 | GO:0061564 |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 2.07e-06 | 8 | 70 | 3 | GO:0071694 | |
| GeneOntologyBiologicalProcess | blood vessel development | STAB2 MEGF8 CLEC14A ENPP1 WNT7A JAG1 LRP1 LAMA4 LTBP1 ACVR1 TNFRSF1A ITGB1 CDH2 NOTCH1 | 2.35e-06 | 929 | 70 | 14 | GO:0001568 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | VLDLR NTNG2 MEGF8 UBE3A WNT7A LRP1 NTNG1 LAMB1 PRKCQ ITGB1 CDH2 NOTCH1 EPHA10 | 2.57e-06 | 802 | 70 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | axonogenesis | NTNG2 MEGF8 WNT7A LRP1 NTNG1 LAMB1 PRKCQ ITGB1 CDH2 NOTCH1 EPHA10 | 3.01e-06 | 566 | 70 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | positive regulation of cardiac epithelial to mesenchymal transition | 3.10e-06 | 9 | 70 | 3 | GO:0062043 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | VLDLR NTNG2 MEGF8 UBE3A WNT7A LRP1 NTNG1 LAMB1 PRKCQ ITGB1 CDH2 NOTCH1 EPHA10 | 3.24e-06 | 819 | 70 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | VLDLR NTNG2 MEGF8 UBE3A WNT7A LRP1 NTNG1 LAMB1 PRKCQ ITGB1 CDH2 NOTCH1 EPHA10 | 3.56e-06 | 826 | 70 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | vasculature development | STAB2 MEGF8 CLEC14A ENPP1 WNT7A JAG1 LRP1 LAMA4 LTBP1 ACVR1 TNFRSF1A ITGB1 CDH2 NOTCH1 | 3.84e-06 | 969 | 70 | 14 | GO:0001944 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 4.28e-06 | 276 | 70 | 8 | GO:0007179 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 5.23e-06 | 74 | 70 | 5 | GO:0002011 | |
| GeneOntologyBiologicalProcess | artery development | 6.00e-06 | 133 | 70 | 6 | GO:0060840 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 6.06e-06 | 11 | 70 | 3 | GO:0035581 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 6.26e-06 | 134 | 70 | 6 | GO:0003279 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | NTNG2 FBN2 MEGF8 WNT7A JAG1 LRP1 LAMA4 NTNG1 LAMB1 ACVR1 CCL20 ITGB1 NOTCH1 TFF2 SORL1 STC1 | 7.13e-06 | 1327 | 70 | 16 | GO:0040012 |
| GeneOntologyBiologicalProcess | cardiac chamber development | 7.60e-06 | 212 | 70 | 7 | GO:0003205 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 9.12e-06 | 218 | 70 | 7 | GO:0090101 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.03e-05 | 412 | 70 | 9 | GO:0090287 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 1.04e-05 | 13 | 70 | 3 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 1.04e-05 | 13 | 70 | 3 | GO:1900116 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | NTNG2 FBN2 WNT7A JAG1 LRP1 LAMA4 NTNG1 LAMB1 ACVR1 CCL20 ITGB1 NOTCH1 TFF2 SORL1 STC1 | 1.06e-05 | 1211 | 70 | 15 | GO:0030334 |
| GeneOntologyBiologicalProcess | endocardial cushion cell differentiation | 1.14e-05 | 2 | 70 | 2 | GO:0061443 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ITGBL1 NTNG2 ZAN SCARF2 JAG1 NTNG1 LAMB1 PRKCQ ACVR1 ITGB1 CDH2 CDH7 MEGF11 NOTCH1 | 1.28e-05 | 1077 | 70 | 14 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of cardiac epithelial to mesenchymal transition | 1.33e-05 | 14 | 70 | 3 | GO:0062042 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | STAB2 MEGF8 CLEC14A ENPP1 WNT7A JAG1 LRP1 ACVR1 TNFRSF1A ITGB1 CDH2 NOTCH1 | 1.77e-05 | 817 | 70 | 12 | GO:0048514 |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 1.79e-05 | 161 | 70 | 6 | GO:0003231 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.79e-05 | 336 | 70 | 8 | GO:0071560 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | NTNG2 FBN2 WNT7A JAG1 LRP1 LAMA4 NTNG1 LAMB1 ACVR1 CCL20 ITGB1 NOTCH1 TFF2 SORL1 STC1 | 2.04e-05 | 1280 | 70 | 15 | GO:2000145 |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 2.07e-05 | 343 | 70 | 8 | GO:0071559 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | STAB2 MEGF8 CLEC14A ENPP1 WNT7A JAG1 LRP1 TRIM71 ACVR1 TNFRSF1A ITGB1 CDH2 ST14 NOTCH1 | 2.09e-05 | 1125 | 70 | 14 | GO:0035239 |
| GeneOntologyBiologicalProcess | neuron projection development | VLDLR LRP12 NTNG2 MEGF8 UBE3A ENPP1 WNT7A LRP1 NTNG1 LAMB1 PRKCQ ITGB1 CDH2 NOTCH1 EPHA10 | 2.14e-05 | 1285 | 70 | 15 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.25e-05 | 347 | 70 | 8 | GO:0090092 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 3.53e-05 | 269 | 70 | 7 | GO:0002064 | |
| GeneOntologyBiologicalProcess | maintenance of protein location | 3.94e-05 | 112 | 70 | 5 | GO:0045185 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | MEGF8 ENPP1 WNT7A JAG1 TRIM71 ACVR1 LY6E ITGB1 ST14 NOTCH1 STC1 | 4.18e-05 | 750 | 70 | 11 | GO:0048729 |
| GeneOntologyBiologicalProcess | tube development | STAB2 FBN1 MEGF8 CLEC14A ENPP1 WNT7A JAG1 LRP1 TRIM71 ACVR1 TNFRSF1A ITGB1 CDH2 ST14 NOTCH1 | 5.85e-05 | 1402 | 70 | 15 | GO:0035295 |
| GeneOntologyBiologicalProcess | negative regulation of extracellular matrix constituent secretion | 6.78e-05 | 4 | 70 | 2 | GO:0003332 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 7.20e-05 | 24 | 70 | 3 | GO:0003177 | |
| GeneOntologyBiologicalProcess | embryo development | HDAC3 FBN2 LRIG1 MEGF8 ENPP1 WNT7A JAG1 WNT8B LAMA4 TRIM71 ACVR1 LY6E ITGB1 ST14 NOTCH1 | 7.74e-05 | 1437 | 70 | 15 | GO:0009790 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 9.16e-05 | 313 | 70 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | neuron development | VLDLR LRP12 NTNG2 MEGF8 UBE3A ENPP1 WNT7A LRP1 NTNG1 LAMB1 PRKCQ ITGB1 CDH2 NOTCH1 EPHA10 | 9.48e-05 | 1463 | 70 | 15 | GO:0048666 |
| GeneOntologyBiologicalProcess | atrial septum primum morphogenesis | 1.13e-04 | 5 | 70 | 2 | GO:0003289 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 1.39e-04 | 713 | 70 | 10 | GO:0048598 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 1.40e-04 | 233 | 70 | 6 | GO:0061351 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | 1.40e-04 | 577 | 70 | 9 | GO:0001667 | |
| GeneOntologyBiologicalProcess | heart valve development | 1.44e-04 | 78 | 70 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | endocardial cell differentiation | 1.69e-04 | 6 | 70 | 2 | GO:0060956 | |
| GeneOntologyBiologicalProcess | septum primum development | 1.69e-04 | 6 | 70 | 2 | GO:0003284 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 1.69e-04 | 6 | 70 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 1.83e-04 | 83 | 70 | 4 | GO:0060976 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 1.91e-04 | 84 | 70 | 4 | GO:1903053 | |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 2.01e-04 | 158 | 70 | 5 | GO:0045446 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | CLEC14A ENPP1 LRP1 TRIM71 SHISA2 PRKCQ ITGB1 NOTCH1 EPHA10 SORL1 | 2.03e-04 | 747 | 70 | 10 | GO:0007169 |
| GeneOntologyBiologicalProcess | secretion | FBN1 ENPP1 WNT7A GNPTAB LRP1 PRKCQ LTBP2 TNFRSF1A LY6E LTBP4 NOTCH1 TFF2 STC1 | 2.07e-04 | 1221 | 70 | 13 | GO:0046903 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 2.18e-04 | 612 | 70 | 9 | GO:0010975 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 2.19e-04 | 161 | 70 | 5 | GO:0003206 | |
| GeneOntologyBiologicalProcess | cardiac atrium morphogenesis | 2.27e-04 | 35 | 70 | 3 | GO:0003209 | |
| GeneOntologyBiologicalProcess | growth | HDAC3 LRP12 MEGF8 UBE3A ENPP1 WNT7A LRP1 PRKCQ LY6E ITGB1 LTBP4 NOTCH1 STC1 | 2.32e-04 | 1235 | 70 | 13 | GO:0040007 |
| GeneOntologyBiologicalProcess | positive regulation of type B pancreatic cell apoptotic process | 2.36e-04 | 7 | 70 | 2 | GO:2000676 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic process involved in morphogenesis | 2.36e-04 | 7 | 70 | 2 | GO:1902339 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 2.37e-04 | 619 | 70 | 9 | GO:0002009 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 2.39e-04 | 89 | 70 | 4 | GO:0060411 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 2.60e-04 | 91 | 70 | 4 | GO:0003281 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 2.71e-04 | 92 | 70 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 2.87e-04 | 377 | 70 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 2.92e-04 | 378 | 70 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 2.97e-04 | 379 | 70 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic process involved in development | 3.14e-04 | 8 | 70 | 2 | GO:1904747 | |
| GeneOntologyBiologicalProcess | cardiac endothelial cell differentiation | 3.14e-04 | 8 | 70 | 2 | GO:0003348 | |
| GeneOntologyBiologicalProcess | cardiac epithelial to mesenchymal transition | 3.38e-04 | 40 | 70 | 3 | GO:0060317 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway | 3.46e-04 | 98 | 70 | 4 | GO:0008543 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 3.52e-04 | 516 | 70 | 8 | GO:0016055 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 3.64e-04 | 41 | 70 | 3 | GO:0035909 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | HDAC3 UBE3A WNT7A LRP1 BIRC3 SPOP ACVR1 TNFRSF1A ITGB1 CDH2 PLSCR1 NOTCH1 TFF2 | 3.78e-04 | 1299 | 70 | 13 | GO:1902533 |
| GeneOntologyBiologicalProcess | endothelium development | 3.85e-04 | 182 | 70 | 5 | GO:0003158 | |
| GeneOntologyBiologicalProcess | stem cell development | 3.88e-04 | 101 | 70 | 4 | GO:0048864 | |
| GeneOntologyBiologicalProcess | cardiac atrium development | 3.91e-04 | 42 | 70 | 3 | GO:0003230 | |
| GeneOntologyBiologicalProcess | cell adhesion involved in heart morphogenesis | 4.02e-04 | 9 | 70 | 2 | GO:0061343 | |
| GeneOntologyBiologicalProcess | axon guidance | 4.13e-04 | 285 | 70 | 6 | GO:0007411 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 4.15e-04 | 185 | 70 | 5 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 4.15e-04 | 185 | 70 | 5 | GO:0035108 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 4.19e-04 | 43 | 70 | 3 | GO:0071711 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 4.20e-04 | 286 | 70 | 6 | GO:0097485 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 4.76e-04 | 410 | 70 | 7 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 4.92e-04 | 192 | 70 | 5 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix constituent secretion | 5.02e-04 | 10 | 70 | 2 | GO:0003330 | |
| GeneOntologyBiologicalProcess | distal tubule development | 5.02e-04 | 10 | 70 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | aortic valve development | 5.12e-04 | 46 | 70 | 3 | GO:0003176 | |
| GeneOntologyCellularComponent | extracellular matrix | NID2 FBN1 FCGBP FBN2 ZAN MEGF6 LRIG1 CLEC14A SBSPON WNT7A LAMA4 LAMB1 MUC5B LTBP1 LTBP2 PLSCR2 ITGB1 CDH2 LTBP4 MUC5AC PLSCR1 FBN3 | 1.25e-16 | 656 | 70 | 22 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | NID2 FBN1 FCGBP FBN2 ZAN MEGF6 LRIG1 CLEC14A SBSPON WNT7A LAMA4 LAMB1 MUC5B LTBP1 LTBP2 PLSCR2 ITGB1 CDH2 LTBP4 MUC5AC PLSCR1 FBN3 | 1.33e-16 | 658 | 70 | 22 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | NID2 FBN1 FBN2 MEGF6 CLEC14A SBSPON LAMA4 LAMB1 LTBP1 LTBP2 PLSCR2 ITGB1 CDH2 LTBP4 PLSCR1 | 1.89e-10 | 530 | 70 | 15 | GO:0062023 |
| GeneOntologyCellularComponent | microfibril | 4.59e-10 | 13 | 70 | 5 | GO:0001527 | |
| GeneOntologyCellularComponent | cell surface | NID2 VLDLR ITGBL1 STAB2 CLEC14A ENPP1 WNT7A LRP1 TNFRSF1A ITGB1 CDH2 VWDE ST14 NOTCH1 SORL1 | 3.18e-06 | 1111 | 70 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | basement membrane | 5.57e-05 | 122 | 70 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | apical part of cell | 1.54e-04 | 592 | 70 | 9 | GO:0045177 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 1.72e-04 | 155 | 70 | 5 | GO:0098685 | |
| GeneOntologyCellularComponent | Golgi lumen | 4.92e-04 | 109 | 70 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | adherens junction | 7.25e-04 | 212 | 70 | 5 | GO:0005912 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.02e-03 | 59 | 70 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 1.57e-03 | 817 | 70 | 9 | GO:0098978 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 2.29e-03 | 78 | 70 | 3 | GO:0048787 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 2.46e-03 | 80 | 70 | 3 | GO:0005905 | |
| GeneOntologyCellularComponent | receptor complex | 3.26e-03 | 581 | 70 | 7 | GO:0043235 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 4.38e-03 | 320 | 70 | 5 | GO:0016323 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 5.11e-03 | 332 | 70 | 5 | GO:0005788 | |
| GeneOntologyCellularComponent | catenin complex | 5.14e-03 | 32 | 70 | 2 | GO:0016342 | |
| GeneOntologyCellularComponent | integrin complex | 5.14e-03 | 32 | 70 | 2 | GO:0008305 | |
| GeneOntologyCellularComponent | apical plasma membrane | 5.78e-03 | 487 | 70 | 6 | GO:0016324 | |
| GeneOntologyCellularComponent | neuromuscular junction | 6.32e-03 | 112 | 70 | 3 | GO:0031594 | |
| GeneOntologyCellularComponent | basal plasma membrane | 6.67e-03 | 354 | 70 | 5 | GO:0009925 | |
| GeneOntologyCellularComponent | membrane raft | 7.31e-03 | 362 | 70 | 5 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 7.48e-03 | 364 | 70 | 5 | GO:0098857 | |
| GeneOntologyCellularComponent | side of membrane | 8.71e-03 | 875 | 70 | 8 | GO:0098552 | |
| GeneOntologyCellularComponent | basal part of cell | 8.72e-03 | 378 | 70 | 5 | GO:0045178 | |
| MousePheno | abnormal skin turgor | 3.16e-06 | 7 | 64 | 3 | MP:0003652 | |
| MousePheno | abnormal limb development | 4.22e-05 | 140 | 64 | 6 | MP:0006279 | |
| MousePheno | abnormal skin appearance | 5.26e-05 | 473 | 64 | 10 | MP:0009931 | |
| MousePheno | abnormal skin morphology | FBN1 FBN2 LDLRAD1 LRIG1 MEGF8 ENPP1 WNT7A JAG1 GNPTAB LAMA4 TRIM71 MUC5B TNFRSF1A LY6E ITGB1 LTBP4 ST14 ADGRL4 | 6.20e-05 | 1455 | 64 | 18 | MP:0002060 |
| Domain | EGF | NID2 VLDLR ITGBL1 NTNG2 STAB2 FBN1 FCGBP FBN2 ZAN MEGF6 MEGF8 SCARF2 CLEC14A JAG1 LRP1 LAMA4 NTNG1 LAMB1 LTBP1 LTBP2 MUC13 LTBP4 VWDE MEGF11 FBN3 NOTCH1 ADGRL4 SORL1 | 2.11e-35 | 235 | 70 | 28 | SM00181 |
| Domain | EGF-like_dom | NID2 VLDLR ITGBL1 NTNG2 STAB2 FBN1 FCGBP FBN2 ZAN MEGF6 MEGF8 SCARF2 CLEC14A JAG1 LRP1 LAMA4 NTNG1 LAMB1 LTBP1 LTBP2 MUC13 LTBP4 VWDE MEGF11 FBN3 NOTCH1 ADGRL4 SORL1 | 1.14e-34 | 249 | 70 | 28 | IPR000742 |
| Domain | EGF-like_CS | NID2 VLDLR NTNG2 STAB2 FBN1 FBN2 ZAN MEGF6 MEGF8 SCARF2 CLEC14A JAG1 LRP1 LAMA4 NTNG1 LAMB1 LTBP1 LTBP2 MUC13 ITGB1 LTBP4 VWDE MEGF11 FBN3 NOTCH1 EPHA10 ADGRL4 SORL1 | 4.48e-34 | 261 | 70 | 28 | IPR013032 |
| Domain | EGF_2 | NID2 VLDLR ITGBL1 NTNG2 STAB2 FBN1 FBN2 ZAN MEGF6 MEGF8 SCARF2 CLEC14A JAG1 LRP1 NTNG1 LAMB1 LTBP1 LTBP2 MUC13 LTBP4 VWDE MEGF11 FBN3 NOTCH1 EPHA10 ADGRL4 SORL1 | 3.50e-32 | 265 | 70 | 27 | PS01186 |
| Domain | EGF_1 | VLDLR ITGBL1 NTNG2 STAB2 FBN1 FBN2 ZAN MEGF6 MEGF8 SCARF2 CLEC14A JAG1 LRP1 LAMA4 NTNG1 LAMB1 LTBP1 LTBP2 MUC13 ITGB1 LTBP4 VWDE MEGF11 FBN3 NOTCH1 | 2.73e-29 | 255 | 70 | 25 | PS00022 |
| Domain | EGF_3 | NID2 VLDLR NTNG2 STAB2 FBN1 FBN2 ZAN MEGF6 MEGF8 SCARF2 CLEC14A JAG1 LRP1 NTNG1 LTBP1 LTBP2 MUC13 LTBP4 VWDE MEGF11 FBN3 NOTCH1 ADGRL4 SORL1 | 1.58e-28 | 235 | 70 | 24 | PS50026 |
| Domain | Growth_fac_rcpt_ | NID2 VLDLR STAB2 FBN1 FBN2 MEGF6 MEGF8 SCARF2 JAG1 LRP1 LAMB1 LTBP1 LTBP2 MUC13 LTBP4 FBN3 NOTCH1 | 1.04e-20 | 156 | 70 | 17 | IPR009030 |
| Domain | ASX_HYDROXYL | NID2 VLDLR FBN1 FBN2 MEGF6 MEGF8 CLEC14A JAG1 LRP1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH1 ADGRL4 | 1.62e-20 | 100 | 70 | 15 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | NID2 VLDLR FBN1 FBN2 MEGF6 MEGF8 CLEC14A JAG1 LRP1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH1 ADGRL4 | 4.07e-20 | 106 | 70 | 15 | IPR000152 |
| Domain | EGF_CA | NID2 VLDLR FBN1 FBN2 MEGF6 MEGF8 JAG1 LRP1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH1 ADGRL4 | 9.99e-20 | 86 | 70 | 14 | PF07645 |
| Domain | EGF_CA | NID2 VLDLR STAB2 FBN1 FBN2 MEGF6 MEGF8 JAG1 LRP1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH1 ADGRL4 | 3.70e-19 | 122 | 70 | 15 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | NID2 VLDLR STAB2 FBN1 FBN2 MEGF6 MEGF8 JAG1 LRP1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH1 ADGRL4 | 4.77e-19 | 124 | 70 | 15 | IPR001881 |
| Domain | EGF_Ca-bd_CS | NID2 VLDLR FBN1 FBN2 MEGF6 MEGF8 JAG1 LRP1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH1 ADGRL4 | 5.97e-19 | 97 | 70 | 14 | IPR018097 |
| Domain | EGF_CA | NID2 VLDLR FBN1 FBN2 MEGF6 MEGF8 JAG1 LRP1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH1 ADGRL4 | 8.06e-19 | 99 | 70 | 14 | PS01187 |
| Domain | EGF_Lam | 5.59e-15 | 35 | 70 | 9 | SM00180 | |
| Domain | Laminin_EGF | 1.28e-14 | 38 | 70 | 9 | IPR002049 | |
| Domain | TB | 1.55e-14 | 7 | 70 | 6 | PF00683 | |
| Domain | EGF_extracell | ITGBL1 NTNG2 STAB2 MEGF6 SCARF2 JAG1 LTBP2 ITGB1 MEGF11 NOTCH1 | 1.82e-14 | 60 | 70 | 10 | IPR013111 |
| Domain | EGF_2 | ITGBL1 NTNG2 STAB2 MEGF6 SCARF2 JAG1 LTBP2 ITGB1 MEGF11 NOTCH1 | 1.82e-14 | 60 | 70 | 10 | PF07974 |
| Domain | EGF | NID2 VLDLR NTNG2 STAB2 ZAN MEGF6 JAG1 LRP1 LTBP1 LTBP2 FBN3 NOTCH1 | 3.98e-14 | 126 | 70 | 12 | PF00008 |
| Domain | - | 6.20e-14 | 8 | 70 | 6 | 3.90.290.10 | |
| Domain | TB | 1.85e-13 | 9 | 70 | 6 | PS51364 | |
| Domain | TB_dom | 1.85e-13 | 9 | 70 | 6 | IPR017878 | |
| Domain | Laminin_EGF | 5.59e-13 | 35 | 70 | 8 | PF00053 | |
| Domain | cEGF | 4.83e-10 | 26 | 70 | 6 | IPR026823 | |
| Domain | cEGF | 4.83e-10 | 26 | 70 | 6 | PF12662 | |
| Domain | hEGF | 7.86e-10 | 28 | 70 | 6 | PF12661 | |
| Domain | EGF_LAM_2 | 1.23e-09 | 30 | 70 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 1.23e-09 | 30 | 70 | 6 | PS01248 | |
| Domain | VWD | 2.71e-09 | 16 | 70 | 5 | SM00216 | |
| Domain | VWF_type-D | 2.71e-09 | 16 | 70 | 5 | IPR001846 | |
| Domain | VWFD | 2.71e-09 | 16 | 70 | 5 | PS51233 | |
| Domain | VWD | 2.71e-09 | 16 | 70 | 5 | PF00094 | |
| Domain | VWC_out | 7.14e-09 | 19 | 70 | 5 | SM00215 | |
| Domain | Ldl_recept_a | 1.62e-08 | 45 | 70 | 6 | PF00057 | |
| Domain | - | 1.85e-08 | 46 | 70 | 6 | 4.10.400.10 | |
| Domain | LDLRA_1 | 2.41e-08 | 48 | 70 | 6 | PS01209 | |
| Domain | LDLRA_2 | 2.74e-08 | 49 | 70 | 6 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 2.74e-08 | 49 | 70 | 6 | IPR002172 | |
| Domain | LDLa | 2.74e-08 | 49 | 70 | 6 | SM00192 | |
| Domain | FBN | 5.04e-08 | 3 | 70 | 3 | IPR011398 | |
| Domain | TIL | 8.75e-08 | 12 | 70 | 4 | PF01826 | |
| Domain | C8 | 8.75e-08 | 12 | 70 | 4 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.26e-07 | 13 | 70 | 4 | IPR014853 | |
| Domain | C8 | 1.26e-07 | 13 | 70 | 4 | SM00832 | |
| Domain | TIL_dom | 1.76e-07 | 14 | 70 | 4 | IPR002919 | |
| Domain | Ldl_recept_b | 1.76e-07 | 14 | 70 | 4 | PF00058 | |
| Domain | LDLRB | 1.76e-07 | 14 | 70 | 4 | PS51120 | |
| Domain | LY | 2.39e-07 | 15 | 70 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.39e-07 | 15 | 70 | 4 | IPR000033 | |
| Domain | VWC | 2.92e-07 | 38 | 70 | 5 | SM00214 | |
| Domain | - | 3.34e-07 | 39 | 70 | 5 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 3.80e-07 | 40 | 70 | 5 | IPR023415 | |
| Domain | VWF_dom | 4.89e-07 | 42 | 70 | 5 | IPR001007 | |
| Domain | 6-blade_b-propeller_TolB-like | 7.78e-07 | 46 | 70 | 5 | IPR011042 | |
| Domain | Notch_dom | 1.75e-06 | 7 | 70 | 3 | IPR000800 | |
| Domain | Notch | 1.75e-06 | 7 | 70 | 3 | PF00066 | |
| Domain | NL | 1.75e-06 | 7 | 70 | 3 | SM00004 | |
| Domain | - | 8.14e-06 | 11 | 70 | 3 | 2.40.155.10 | |
| Domain | GFP-like | 8.14e-06 | 11 | 70 | 3 | IPR023413 | |
| Domain | EGF_3 | 1.08e-05 | 12 | 70 | 3 | PF12947 | |
| Domain | EGF_dom | 1.08e-05 | 12 | 70 | 3 | IPR024731 | |
| Domain | Laminin_N | 2.73e-05 | 16 | 70 | 3 | IPR008211 | |
| Domain | LAMININ_NTER | 2.73e-05 | 16 | 70 | 3 | PS51117 | |
| Domain | Laminin_N | 2.73e-05 | 16 | 70 | 3 | PF00055 | |
| Domain | LamNT | 2.73e-05 | 16 | 70 | 3 | SM00136 | |
| Domain | TILa | 4.14e-05 | 3 | 70 | 2 | PF12714 | |
| Domain | TILa_dom | 4.14e-05 | 3 | 70 | 2 | IPR025615 | |
| Domain | Scramblase | 1.37e-04 | 5 | 70 | 2 | PF03803 | |
| Domain | LNR | 1.37e-04 | 5 | 70 | 2 | PS50258 | |
| Domain | Scramblase | 1.37e-04 | 5 | 70 | 2 | IPR005552 | |
| Domain | WxxW_domain | 2.06e-04 | 6 | 70 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 2.06e-04 | 6 | 70 | 2 | PF13330 | |
| Domain | VWFC_1 | 3.29e-04 | 36 | 70 | 3 | PS01208 | |
| Domain | VWFC_2 | 3.87e-04 | 38 | 70 | 3 | PS50184 | |
| Domain | Integrin_bsu | 4.90e-04 | 9 | 70 | 2 | IPR015812 | |
| Domain | Integin_beta_N | 4.90e-04 | 9 | 70 | 2 | IPR033760 | |
| Domain | INTEGRIN_BETA | 4.90e-04 | 9 | 70 | 2 | PS00243 | |
| Domain | PSI_integrin | 4.90e-04 | 9 | 70 | 2 | PF17205 | |
| Domain | Somatomedin_B_dom | 6.11e-04 | 10 | 70 | 2 | IPR001212 | |
| Domain | SMB_1 | 6.11e-04 | 10 | 70 | 2 | PS00524 | |
| Domain | SMB_2 | 6.11e-04 | 10 | 70 | 2 | PS50958 | |
| Domain | CUB | 8.21e-04 | 49 | 70 | 3 | PF00431 | |
| Domain | CUB | 8.71e-04 | 50 | 70 | 3 | SM00042 | |
| Domain | - | 9.77e-04 | 52 | 70 | 3 | 2.60.120.290 | |
| Domain | CUB | 1.03e-03 | 53 | 70 | 3 | PS01180 | |
| Domain | CUB_dom | 1.28e-03 | 57 | 70 | 3 | IPR000859 | |
| Domain | Glyco_hormone_CN | 1.41e-03 | 15 | 70 | 2 | IPR006208 | |
| Domain | Cys_knot | 1.41e-03 | 15 | 70 | 2 | PF00007 | |
| Domain | EMI_domain | 1.61e-03 | 16 | 70 | 2 | IPR011489 | |
| Domain | Ald_DH_CS_GLU | 1.61e-03 | 16 | 70 | 2 | IPR029510 | |
| Domain | Ald_DH_CS_CYS | 1.82e-03 | 17 | 70 | 2 | IPR016160 | |
| Domain | EMI | 1.82e-03 | 17 | 70 | 2 | PS51041 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 2.04e-03 | 18 | 70 | 2 | PS00687 | |
| Domain | CTCK_1 | 2.04e-03 | 18 | 70 | 2 | PS01185 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 2.04e-03 | 18 | 70 | 2 | PS00070 | |
| Domain | Wnt | 2.27e-03 | 19 | 70 | 2 | IPR005817 | |
| Domain | Wnt_CS | 2.27e-03 | 19 | 70 | 2 | IPR018161 | |
| Domain | wnt | 2.27e-03 | 19 | 70 | 2 | PF00110 | |
| Domain | Ald_DH_C | 2.27e-03 | 19 | 70 | 2 | IPR016163 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 9.94e-11 | 37 | 56 | 7 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.62e-10 | 44 | 56 | 7 | M26969 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.50e-09 | 32 | 56 | 6 | MM14854 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 8.80e-09 | 39 | 56 | 6 | MM14601 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 4.12e-08 | 25 | 56 | 5 | M39713 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.46e-07 | 300 | 56 | 10 | M610 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.95e-07 | 15 | 56 | 4 | MM14922 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.74e-07 | 38 | 56 | 5 | MM14874 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.16e-07 | 258 | 56 | 9 | MM14572 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.11e-06 | 47 | 56 | 5 | M646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 3.28e-06 | 8 | 56 | 3 | M47850 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.67e-06 | 30 | 56 | 4 | M27216 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 7.10e-06 | 68 | 56 | 5 | M27303 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.31e-05 | 77 | 56 | 5 | MM14670 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 3.21e-05 | 16 | 56 | 3 | M27410 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 3.46e-05 | 94 | 56 | 5 | M1041 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 3.88e-05 | 17 | 56 | 3 | M27412 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 4.89e-05 | 101 | 56 | 5 | M39448 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.50e-05 | 19 | 56 | 3 | MM15512 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 7.51e-05 | 21 | 56 | 3 | MM15706 | |
| Pathway | WP_GASTRIN_SIGNALING | 9.08e-05 | 115 | 56 | 5 | M39866 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 9.94e-05 | 23 | 56 | 3 | M556 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.03e-04 | 118 | 56 | 5 | MM15588 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 1.03e-04 | 118 | 56 | 5 | M39852 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.11e-04 | 120 | 56 | 5 | MM14982 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.30e-04 | 124 | 56 | 5 | M27285 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.34e-04 | 66 | 56 | 4 | M18 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.42e-04 | 67 | 56 | 4 | MM15345 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.45e-04 | 26 | 56 | 3 | M27483 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.88e-04 | 72 | 56 | 4 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.98e-04 | 73 | 56 | 4 | MM15906 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.98e-04 | 73 | 56 | 4 | MM15126 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.23e-04 | 30 | 56 | 3 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.23e-04 | 30 | 56 | 3 | MM15517 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.52e-04 | 143 | 56 | 5 | M27275 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.69e-04 | 79 | 56 | 4 | M27643 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 3.21e-04 | 7 | 56 | 2 | M27199 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.40e-04 | 84 | 56 | 4 | M3228 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 4.36e-04 | 161 | 56 | 5 | M39770 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 4.36e-04 | 161 | 56 | 5 | M27871 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 5.66e-04 | 96 | 56 | 4 | M39834 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 5.66e-04 | 96 | 56 | 4 | MM14592 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.69e-04 | 41 | 56 | 3 | M27778 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 5.88e-04 | 97 | 56 | 4 | MM15926 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 6.11e-04 | 42 | 56 | 3 | M174 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 6.55e-04 | 43 | 56 | 3 | M53 | |
| Pathway | BIOCARTA_SODD_PATHWAY | 6.83e-04 | 10 | 56 | 2 | M2699 | |
| Pathway | KEGG_LIMONENE_AND_PINENE_DEGRADATION | 6.83e-04 | 10 | 56 | 2 | M17395 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 7.01e-04 | 44 | 56 | 3 | M13720 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 7.39e-04 | 381 | 56 | 7 | M48063 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 7.99e-04 | 46 | 56 | 3 | M239 | |
| Pathway | WP_CANCER_PATHWAYS | 8.23e-04 | 507 | 56 | 8 | M48302 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 8.33e-04 | 11 | 56 | 2 | MM15405 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.12e-04 | 109 | 56 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.76e-04 | 111 | 56 | 4 | M27416 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 9.97e-04 | 12 | 56 | 2 | M14663 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 9.97e-04 | 12 | 56 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.18e-03 | 13 | 56 | 2 | M47423 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 1.18e-03 | 13 | 56 | 2 | M42551 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.37e-03 | 14 | 56 | 2 | M27808 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 1.49e-03 | 57 | 56 | 3 | M48326 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.57e-03 | 58 | 56 | 3 | M29616 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.57e-03 | 15 | 56 | 2 | M27202 | |
| Pathway | WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1 | 1.57e-03 | 15 | 56 | 2 | M45549 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.65e-03 | 59 | 56 | 3 | M27218 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.73e-03 | 60 | 56 | 3 | MM15636 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.77e-03 | 325 | 56 | 6 | M12868 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.79e-03 | 16 | 56 | 2 | M47424 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.90e-03 | 62 | 56 | 3 | M546 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 2.03e-03 | 17 | 56 | 2 | M39389 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 2.03e-03 | 17 | 56 | 2 | M39443 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.29e-03 | 140 | 56 | 4 | M587 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 2.54e-03 | 19 | 56 | 2 | M47836 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.08e-03 | 250 | 56 | 5 | M27554 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.15e-03 | 74 | 56 | 3 | M616 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.40e-03 | 76 | 56 | 3 | M27219 | |
| Pathway | WP_PROGERIAASSOCIATED_LIPODYSTROPHY | 3.40e-03 | 22 | 56 | 2 | M42534 | |
| Pathway | KEGG_BETA_ALANINE_METABOLISM | 3.40e-03 | 22 | 56 | 2 | M2668 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.72e-03 | 23 | 56 | 2 | MM14954 | |
| Pathway | REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING | 3.72e-03 | 23 | 56 | 2 | MM15177 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 4.04e-03 | 24 | 56 | 2 | M15926 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 4.39e-03 | 25 | 56 | 2 | MM14940 | |
| Pathway | REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING | 4.39e-03 | 25 | 56 | 2 | M27435 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 4.39e-03 | 25 | 56 | 2 | M605 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.51e-03 | 84 | 56 | 3 | M7098 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 4.74e-03 | 26 | 56 | 2 | M27239 | |
| Pubmed | 1.50e-11 | 4 | 70 | 4 | 12429738 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.23e-11 | 97 | 70 | 8 | 27559042 | |
| Pubmed | 8.40e-11 | 175 | 70 | 9 | 28071719 | ||
| Pubmed | 1.09e-10 | 118 | 70 | 8 | 21078624 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | LRP12 FBN1 FBN2 MEGF8 ENPP1 GNPTAB LRP1 LAMA4 LAMB1 LTBP1 LTBP2 TNFRSF1A ITGB1 CDH2 PLSCR1 NOTCH1 SORL1 | 1.77e-10 | 1201 | 70 | 17 | 35696571 |
| Pubmed | 6.02e-10 | 146 | 70 | 8 | 27068509 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.84e-09 | 248 | 70 | 9 | 24006456 | |
| Pubmed | 1.88e-09 | 9 | 70 | 4 | 12122015 | ||
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 17293099 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.11e-08 | 135 | 70 | 7 | 28675934 | |
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 1.18e-08 | 37 | 70 | 5 | 34323105 | |
| Pubmed | 2.02e-08 | 41 | 70 | 5 | 22675208 | ||
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 15611103 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 3.12e-08 | 4 | 70 | 3 | 25034023 | |
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 3.12e-08 | 4 | 70 | 3 | 11104663 | |
| Pubmed | Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo. | 3.12e-08 | 4 | 70 | 3 | 21979816 | |
| Pubmed | 4.26e-08 | 164 | 70 | 7 | 32409323 | ||
| Pubmed | 4.82e-08 | 167 | 70 | 7 | 22159717 | ||
| Pubmed | 5.64e-08 | 50 | 70 | 5 | 23658023 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 5.82e-08 | 101 | 70 | 6 | 20551380 | |
| Pubmed | 7.79e-08 | 5 | 70 | 3 | 34411563 | ||
| Pubmed | 8.77e-08 | 21 | 70 | 4 | 23325811 | ||
| Pubmed | 1.07e-07 | 22 | 70 | 4 | 38794925 | ||
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 19349279 | ||
| Pubmed | Expression of the phospholipid scramblase (PLSCR) gene family during the acute phase response. | 1.55e-07 | 6 | 70 | 3 | 17590392 | |
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 18254948 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ITGBL1 FBN1 MEGF6 MEGF8 UBE3A LTBP1 LTBP4 PLSCR1 MEGF11 NOTCH1 | 1.80e-07 | 560 | 70 | 10 | 21653829 |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 2.18e-07 | 26 | 70 | 4 | 34189436 | |
| Pubmed | Notch1 haploinsufficiency causes ascending aortic aneurysms in mice. | 2.72e-07 | 7 | 70 | 3 | 29093270 | |
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 10930463 | ||
| Pubmed | 3.35e-07 | 71 | 70 | 5 | 33541421 | ||
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 3.96e-07 | 30 | 70 | 4 | 32882513 | |
| Pubmed | 4.13e-07 | 613 | 70 | 10 | 22268729 | ||
| Pubmed | 6.50e-07 | 9 | 70 | 3 | 20005821 | ||
| Pubmed | 6.50e-07 | 9 | 70 | 3 | 38844137 | ||
| Pubmed | 6.57e-07 | 152 | 70 | 6 | 11044609 | ||
| Pubmed | 6.83e-07 | 153 | 70 | 6 | 25037231 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 8.76e-07 | 86 | 70 | 5 | 28327460 | |
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 9.28e-07 | 10 | 70 | 3 | 18590826 | |
| Pubmed | 9.28e-07 | 10 | 70 | 3 | 24715457 | ||
| Pubmed | 1.05e-06 | 383 | 70 | 8 | 19453261 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 1.16e-06 | 91 | 70 | 5 | 28558017 | |
| Pubmed | Notch-Tnf signalling is required for development and homeostasis of arterial valves. | 1.27e-06 | 11 | 70 | 3 | 26491108 | |
| Pubmed | WNT/RYK signaling restricts goblet cell differentiation during lung development and repair. | 1.59e-06 | 42 | 70 | 4 | 31776260 | |
| Pubmed | 1.70e-06 | 12 | 70 | 3 | 26405179 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.95e-06 | 101 | 70 | 5 | 23382219 | |
| Pubmed | Basement membranes in skin are differently affected by lack of nidogen 1 and 2. | 2.20e-06 | 13 | 70 | 3 | 18356808 | |
| Pubmed | 2.20e-06 | 13 | 70 | 3 | 27991863 | ||
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 25401743 | ||
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 22797898 | ||
| Pubmed | 2.88e-06 | 196 | 70 | 6 | 19334288 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 3.49e-06 | 15 | 70 | 3 | 12921739 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 3.49e-06 | 15 | 70 | 3 | 15895400 | |
| Pubmed | 3.62e-06 | 608 | 70 | 9 | 16713569 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 7513696 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12399449 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21851253 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 37146737 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25858550 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 3.99e-06 | 2 | 70 | 2 | 14988081 | |
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 3.99e-06 | 2 | 70 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 3.99e-06 | 2 | 70 | 2 | 21440062 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15131124 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15563276 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17621824 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 24317696 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25047496 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22391959 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 3.99e-06 | 2 | 70 | 2 | 35776514 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 3.99e-06 | 2 | 70 | 2 | 20404337 | |
| Pubmed | The N-Terminal Region of Fibrillin-1 Mediates a Bipartite Interaction with LTBP1. | 3.99e-06 | 2 | 70 | 2 | 28669633 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 24327612 | ||
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 3.99e-06 | 2 | 70 | 2 | 8791520 | |
| Pubmed | Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor. | 3.99e-06 | 2 | 70 | 2 | 23339193 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26746425 | ||
| Pubmed | A mutation in EGF repeat-8 of Notch discriminates between Serrate/Jagged and Delta family ligands. | 3.99e-06 | 2 | 70 | 2 | 23197537 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 3.99e-06 | 2 | 70 | 2 | 8307578 | |
| Pubmed | Laminets: laminin- and netrin-related genes expressed in distinct neuronal subsets. | 3.99e-06 | 2 | 70 | 2 | 11906208 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23667679 | ||
| Pubmed | Human netrin-G1 isoforms show evidence of differential expression. | 3.99e-06 | 2 | 70 | 2 | 15901489 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 14699139 | ||
| Pubmed | Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. | 3.99e-06 | 2 | 70 | 2 | 18079963 | |
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 3.99e-06 | 2 | 70 | 2 | 28607090 | |
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 3.99e-06 | 2 | 70 | 2 | 7744963 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26408953 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 38783634 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 3.99e-06 | 2 | 70 | 2 | 18006876 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 18660822 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 31030254 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25842263 | ||
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 3.99e-06 | 2 | 70 | 2 | 23527003 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 3.99e-06 | 2 | 70 | 2 | 24833718 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30943513 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16540890 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12509439 | ||
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 3.99e-06 | 2 | 70 | 2 | 24484584 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22348356 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 3.99e-06 | 2 | 70 | 2 | 27845589 | |
| Pubmed | Jagged1 and Notch1 help edit M cell patterning in Peyer's patch follicle epithelium. | 3.99e-06 | 2 | 70 | 2 | 22504165 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 24265020 | ||
| Interaction | FBXO2 interactions | NID2 FBN1 FBN2 LRIG1 MEGF8 ENPP1 WNT7A JAG1 GNPTAB LAMA4 LAMB1 ITGB1 LTBP4 ST14 NOTCH1 SORL1 | 6.08e-13 | 411 | 70 | 16 | int:FBXO2 |
| Interaction | NTN5 interactions | 1.48e-12 | 24 | 70 | 7 | int:NTN5 | |
| Interaction | IGFL3 interactions | 7.38e-09 | 75 | 70 | 7 | int:IGFL3 | |
| Interaction | MFAP5 interactions | 2.53e-08 | 52 | 70 | 6 | int:MFAP5 | |
| Interaction | ZNF408 interactions | 3.83e-08 | 145 | 70 | 8 | int:ZNF408 | |
| Interaction | ZFP41 interactions | 4.45e-08 | 57 | 70 | 6 | int:ZFP41 | |
| Interaction | FBN2 interactions | 9.92e-08 | 65 | 70 | 6 | int:FBN2 | |
| Interaction | CACNA1A interactions | 2.32e-07 | 123 | 70 | 7 | int:CACNA1A | |
| Interaction | CFC1 interactions | 2.73e-07 | 126 | 70 | 7 | int:CFC1 | |
| Interaction | FBXO6 interactions | FBN2 MEGF8 ENPP1 LRP1 LAMB1 MUC5B LTBP1 ALDH1B1 ITGB1 CDH2 LTBP4 VWDE SORL1 | 9.60e-07 | 717 | 70 | 13 | int:FBXO6 |
| Interaction | LGALS1 interactions | 2.16e-06 | 332 | 70 | 9 | int:LGALS1 | |
| Interaction | HRG interactions | 2.63e-06 | 63 | 70 | 5 | int:HRG | |
| Interaction | ZNF74 interactions | 5.72e-06 | 34 | 70 | 4 | int:ZNF74 | |
| Interaction | FBLN1 interactions | 5.74e-06 | 129 | 70 | 6 | int:FBLN1 | |
| Interaction | MFAP2 interactions | 8.63e-06 | 12 | 70 | 3 | int:MFAP2 | |
| Interaction | IGFBP4 interactions | 1.23e-05 | 41 | 70 | 4 | int:IGFBP4 | |
| Interaction | WNT3A interactions | 2.51e-05 | 49 | 70 | 4 | int:WNT3A | |
| Interaction | ODAPH interactions | 2.51e-05 | 49 | 70 | 4 | int:ODAPH | |
| Interaction | FOXD4L6 interactions | 2.51e-05 | 49 | 70 | 4 | int:FOXD4L6 | |
| Interaction | DEFA1 interactions | 2.55e-05 | 100 | 70 | 5 | int:DEFA1 | |
| Interaction | FBN1 interactions | 2.95e-05 | 51 | 70 | 4 | int:FBN1 | |
| Interaction | HOXA1 interactions | 3.19e-05 | 356 | 70 | 8 | int:HOXA1 | |
| Interaction | VCAN interactions | 3.70e-05 | 54 | 70 | 4 | int:VCAN | |
| Interaction | ATXN7 interactions | 3.86e-05 | 109 | 70 | 5 | int:ATXN7 | |
| Interaction | ATN1 interactions | 4.72e-05 | 187 | 70 | 6 | int:ATN1 | |
| Interaction | LYPD1 interactions | 4.91e-05 | 58 | 70 | 4 | int:LYPD1 | |
| Interaction | LYZL1 interactions | 5.65e-05 | 118 | 70 | 5 | int:LYZL1 | |
| Interaction | PRG2 interactions | 5.89e-05 | 285 | 70 | 7 | int:PRG2 | |
| Interaction | STC1 interactions | 7.10e-05 | 4 | 70 | 2 | int:STC1 | |
| Interaction | ZDHHC15 interactions | 7.43e-05 | 125 | 70 | 5 | int:ZDHHC15 | |
| Interaction | THBS1 interactions | 8.01e-05 | 127 | 70 | 5 | int:THBS1 | |
| Interaction | CANX interactions | VLDLR CLEC14A ENPP1 WNT7A GRK6 JAG1 LRP1 BIRC3 ACVR1 ITGB1 CDH2 BANF1 EPHA10 SORL1 | 9.31e-05 | 1261 | 70 | 14 | int:CANX |
| Interaction | NOTCH2 interactions | 1.07e-04 | 423 | 70 | 8 | int:NOTCH2 | |
| Interaction | NTF3 interactions | 1.11e-04 | 27 | 70 | 3 | int:NTF3 | |
| Interaction | MFNG interactions | 1.11e-04 | 27 | 70 | 3 | int:MFNG | |
| Interaction | GFI1B interactions | 1.11e-04 | 136 | 70 | 5 | int:GFI1B | |
| Interaction | SDF2L1 interactions | 1.26e-04 | 322 | 70 | 7 | int:SDF2L1 | |
| Interaction | ELN interactions | 1.37e-04 | 29 | 70 | 3 | int:ELN | |
| Interaction | SLURP1 interactions | 1.45e-04 | 144 | 70 | 5 | int:SLURP1 | |
| Interaction | MBD1 interactions | 1.49e-04 | 77 | 70 | 4 | int:MBD1 | |
| Interaction | ZNF707 interactions | 1.65e-04 | 79 | 70 | 4 | int:ZNF707 | |
| Interaction | ZNF101 interactions | 2.03e-04 | 33 | 70 | 3 | int:ZNF101 | |
| Interaction | VEGFB interactions | 2.22e-04 | 34 | 70 | 3 | int:VEGFB | |
| Interaction | SIRPD interactions | 2.29e-04 | 86 | 70 | 4 | int:SIRPD | |
| Interaction | MDK interactions | 2.84e-04 | 91 | 70 | 4 | int:MDK | |
| Interaction | GREM2 interactions | 2.87e-04 | 37 | 70 | 3 | int:GREM2 | |
| Interaction | ELSPBP1 interactions | 2.96e-04 | 92 | 70 | 4 | int:ELSPBP1 | |
| Interaction | VEGFD interactions | 3.10e-04 | 38 | 70 | 3 | int:VEGFD | |
| Interaction | LAMA4 interactions | 3.62e-04 | 40 | 70 | 3 | int:LAMA4 | |
| Interaction | PTPRK interactions | 3.77e-04 | 177 | 70 | 5 | int:PTPRK | |
| Interaction | HSPG2 interactions | 3.77e-04 | 98 | 70 | 4 | int:HSPG2 | |
| Interaction | PSG8 interactions | 3.89e-04 | 41 | 70 | 3 | int:PSG8 | |
| Interaction | NMRK2 interactions | 4.21e-04 | 9 | 70 | 2 | int:NMRK2 | |
| Interaction | EDN3 interactions | 5.45e-04 | 108 | 70 | 4 | int:EDN3 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 7.47e-08 | 4 | 49 | 3 | 628 | |
| GeneFamily | Low density lipoprotein receptors | 5.25e-06 | 13 | 49 | 3 | 634 | |
| GeneFamily | CD molecules|Mucins | 2.40e-05 | 21 | 49 | 3 | 648 | |
| GeneFamily | Phospholipid scramblases | 7.16e-05 | 5 | 49 | 2 | 954 | |
| GeneFamily | Netrins | 1.07e-04 | 6 | 49 | 2 | 661 | |
| GeneFamily | CD molecules|Integrin beta subunits | 2.56e-04 | 9 | 49 | 2 | 1159 | |
| GeneFamily | Laminin subunits | 4.67e-04 | 12 | 49 | 2 | 626 | |
| GeneFamily | Aldehyde dehydrogenases | 1.19e-03 | 19 | 49 | 2 | 398 | |
| GeneFamily | Wnt family|Endogenous ligands | 1.19e-03 | 19 | 49 | 2 | 360 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 2.42e-03 | 27 | 49 | 2 | 1253 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.16e-03 | 394 | 49 | 5 | 471 | |
| Coexpression | NABA_MATRISOME | NID2 NTNG2 FBN1 FBN2 MEGF6 MEGF8 CLEC14A SBSPON WNT7A WNT8B LAMA4 NTNG1 LAMB1 PAPPA MUC5B LTBP1 LTBP2 MUC13 CCL20 LTBP4 MUC5AC VWDE MEGF11 ST14 FBN3 | 5.92e-18 | 1026 | 70 | 25 | M5889 |
| Coexpression | NABA_MATRISOME | NID2 NTNG2 FBN1 FBN2 MEGF6 MEGF8 CLEC14A SBSPON WNT7A WNT8B LAMA4 NTNG1 LAMB1 PAPPA MUC5B LTBP1 LTBP2 MUC13 CCL20 LTBP4 MUC5AC VWDE MEGF11 ST14 | 5.44e-17 | 1008 | 70 | 24 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 NTNG2 FBN1 FBN2 SBSPON LAMA4 NTNG1 LAMB1 LTBP1 LTBP2 LTBP4 VWDE FBN3 | 5.00e-15 | 196 | 70 | 13 | M3008 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 NTNG2 FBN1 FBN2 SBSPON LAMA4 NTNG1 LAMB1 LTBP1 LTBP2 LTBP4 VWDE | 1.16e-13 | 191 | 70 | 12 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | NID2 NTNG2 FBN1 FBN2 SBSPON LAMA4 NTNG1 LAMB1 LTBP1 LTBP2 LTBP4 VWDE FBN3 | 3.92e-13 | 275 | 70 | 13 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | NID2 NTNG2 FBN1 FBN2 SBSPON LAMA4 NTNG1 LAMB1 LTBP1 LTBP2 LTBP4 VWDE | 7.00e-12 | 270 | 70 | 12 | MM17057 |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | BCL6B NID2 MEGF6 CLEC14A LAMA4 LAMB1 ACVR1 LY6E CDH2 NOTCH1 ADGRL4 | 2.34e-08 | 440 | 70 | 11 | M39039 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 7.19e-08 | 40 | 70 | 5 | M5887 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | BCL6B FBN1 SCARF2 CLEC14A LRP1 LAMA4 PAPPA LTBP2 LY6E ZNF687 STC1 | 9.46e-08 | 505 | 70 | 11 | M39167 |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | NID2 FBN1 JAG1 LAMA4 LAMB1 PAPPA LTBP1 LTBP2 ACVR1 ITGB1 NOTCH1 STC1 | 2.31e-07 | 681 | 70 | 12 | M39175 |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 4.28e-07 | 257 | 70 | 8 | M13867 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | MEGF6 MEGF8 CLEC14A WNT7A WNT8B PAPPA MUC5B MUC13 CCL20 MUC5AC MEGF11 ST14 | 5.41e-07 | 738 | 70 | 12 | MM17058 |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 5.49e-07 | 365 | 70 | 9 | M39018 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | MEGF6 MEGF8 CLEC14A WNT7A WNT8B PAPPA MUC5B MUC13 CCL20 MUC5AC MEGF11 ST14 | 6.51e-07 | 751 | 70 | 12 | M5885 |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 8.56e-07 | 385 | 70 | 9 | M39264 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.29e-06 | 35 | 70 | 4 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.58e-06 | 36 | 70 | 4 | MM1212 | |
| Coexpression | BMI1_DN.V1_UP | 2.74e-06 | 147 | 70 | 6 | M2782 | |
| Coexpression | ONDER_CDH1_SIGNALING_VIA_CTNNB1 | 3.08e-06 | 84 | 70 | 5 | M15484 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | NID2 NTNG2 FBN1 FBN2 SCARF2 CLEC14A WNT7A PAPPA SHISA2 LTBP2 CDH7 MEGF11 EPHA10 | 3.09e-06 | 1035 | 70 | 13 | M9898 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | BCL6B NID2 MEGF6 CLEC14A JAG1 LAMA4 LAMB1 ACVR1 TNFRSF1A ITGB1 PLSCR1 ADGRL4 | 3.71e-06 | 888 | 70 | 12 | M39049 |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 5.49e-06 | 362 | 70 | 8 | M39176 | |
| Coexpression | JIANG_TIP30_TARGETS_UP | 6.99e-06 | 46 | 70 | 4 | M12641 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 8.51e-06 | 179 | 70 | 6 | M39308 | |
| Coexpression | LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE | 9.02e-06 | 49 | 70 | 4 | M2899 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 9.79e-06 | 50 | 70 | 4 | M1259 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.15e-05 | 52 | 70 | 4 | MM1118 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 1.56e-05 | 117 | 70 | 5 | M39300 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.60e-05 | 200 | 70 | 6 | M5930 | |
| Coexpression | GSE38304_MYC_NEG_VS_POS_GC_BCELL_DN | 1.60e-05 | 200 | 70 | 6 | M9274 | |
| Coexpression | MANALO_HYPOXIA_UP | 1.84e-05 | 205 | 70 | 6 | M259 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 1.90e-05 | 59 | 70 | 4 | M47989 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYL4_POS_SMC_CELL | 2.07e-05 | 124 | 70 | 5 | M45673 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 2.09e-05 | 721 | 70 | 10 | M1999 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | DIPK1C NID2 ENPP1 WNT7A JAG1 LAMB1 PAPPA SHISA2 PRKCQ MEGF11 ST14 NOTCH1 | 2.49e-05 | 1074 | 70 | 12 | M1941 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL | 2.64e-05 | 589 | 70 | 9 | M45662 | |
| Coexpression | MEL18_DN.V1_UP | 3.83e-05 | 141 | 70 | 5 | M2784 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 3.96e-05 | 71 | 70 | 4 | M2948 | |
| Coexpression | LU_TUMOR_ANGIOGENESIS_UP | 4.02e-05 | 25 | 70 | 3 | M9946 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 4.31e-05 | 352 | 70 | 7 | M17471 | |
| Coexpression | CUI_DEVELOPING_HEART_C4_ENDOTHELIAL_CELL | 4.53e-05 | 146 | 70 | 5 | M39301 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 4.77e-05 | 795 | 70 | 10 | M39050 | |
| Coexpression | ROZANOV_MMP14_TARGETS_UP | 8.02e-05 | 267 | 70 | 6 | M12890 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 8.19e-05 | 268 | 70 | 6 | M45796 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.12e-04 | 35 | 70 | 3 | MM17054 | |
| Coexpression | VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 | 1.33e-04 | 37 | 70 | 3 | M16643 | |
| Coexpression | WINZEN_DEGRADED_VIA_KHSRP | 1.51e-04 | 100 | 70 | 4 | M2352 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.73e-04 | 194 | 70 | 5 | M39122 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_VASCULAR_ENDOTHELIAL_CELLS | 1.75e-04 | 104 | 70 | 4 | M40225 | |
| Coexpression | GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN | 1.90e-04 | 198 | 70 | 5 | M3557 | |
| Coexpression | GSE11057_PBMC_VS_MEM_CD4_TCELL_DN | 1.90e-04 | 198 | 70 | 5 | M3121 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_UP | 1.95e-04 | 199 | 70 | 5 | M5406 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TCONV_UP | 1.95e-04 | 199 | 70 | 5 | M5745 | |
| Coexpression | GSE22886_TCELL_VS_BCELL_NAIVE_UP | 1.95e-04 | 199 | 70 | 5 | M4425 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 1.95e-04 | 8 | 70 | 2 | M9884 | |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 1.96e-04 | 107 | 70 | 4 | M4913 | |
| Coexpression | GSE27786_CD4_VS_CD8_TCELL_UP | 1.99e-04 | 200 | 70 | 5 | M4819 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_UP | 1.99e-04 | 200 | 70 | 5 | M9635 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN | 1.99e-04 | 200 | 70 | 5 | M9657 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_UP | 1.99e-04 | 200 | 70 | 5 | M5953 | |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN | 1.99e-04 | 200 | 70 | 5 | M3488 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN | 1.99e-04 | 200 | 70 | 5 | M7143 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING | 2.22e-04 | 322 | 70 | 6 | MM3786 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 2.24e-04 | 780 | 70 | 9 | M2324 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 2.83e-04 | 805 | 70 | 9 | MM1067 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_MESENCHYMAL | 2.84e-04 | 216 | 70 | 5 | M2122 | |
| Coexpression | NABA_SECRETED_FACTORS | 2.88e-04 | 338 | 70 | 6 | MM17064 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.89e-04 | 479 | 70 | 7 | M2573 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 3.03e-04 | 120 | 70 | 4 | M42505 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 3.04e-04 | 483 | 70 | 7 | MM1082 | |
| Coexpression | NABA_SECRETED_FACTORS | 3.12e-04 | 343 | 70 | 6 | M5883 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN | 3.27e-04 | 648 | 70 | 8 | M14371 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL | 3.44e-04 | 124 | 70 | 4 | M45686 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 3.44e-04 | 493 | 70 | 7 | M19391 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 3.54e-04 | 125 | 70 | 4 | M1320 | |
| Coexpression | TRAVAGLINI_LUNG_MUCOUS_CELL | 3.54e-04 | 125 | 70 | 4 | M41656 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_UP | 3.78e-04 | 662 | 70 | 8 | M8124 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | 3.97e-04 | 359 | 70 | 6 | M15193 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 4.02e-04 | 233 | 70 | 5 | M13273 | |
| Coexpression | SASAKI_TARGETS_OF_TP73_AND_TP63 | 4.56e-04 | 12 | 70 | 2 | M17374 | |
| Coexpression | JONES_OVARY_MACROPHAGE | 4.87e-04 | 243 | 70 | 5 | M48355 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 5.01e-04 | 137 | 70 | 4 | M40313 | |
| Coexpression | PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP | 5.01e-04 | 137 | 70 | 4 | MM886 | |
| Coexpression | DELACROIX_RARG_BOUND_MEF | 5.21e-04 | 378 | 70 | 6 | MM1077 | |
| Coexpression | ALCALAY_AML_BY_NPM1_LOCALIZATION_UP | 5.44e-04 | 140 | 70 | 4 | M9377 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_VASCULAR_ENDOTHELIAL_CELLS | 5.74e-04 | 142 | 70 | 4 | M40152 | |
| Coexpression | KRAS.300_UP.V1_UP | 5.89e-04 | 143 | 70 | 4 | M2875 | |
| Coexpression | BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP | 6.05e-04 | 144 | 70 | 4 | M34020 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_2B | 6.06e-04 | 389 | 70 | 6 | M4995 | |
| Coexpression | BMI1_DN_MEL18_DN.V1_UP | 6.21e-04 | 145 | 70 | 4 | M2779 | |
| Coexpression | TRAVAGLINI_LUNG_GOBLET_CELL | 6.70e-04 | 148 | 70 | 4 | M41655 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 6.76e-04 | 64 | 70 | 3 | M2572 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 6.81e-04 | 909 | 70 | 9 | M41018 | |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_UP | 6.82e-04 | 398 | 70 | 6 | M4872 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 7.22e-04 | 15 | 70 | 2 | MM402 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 7.26e-04 | 1115 | 70 | 10 | M10371 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | 7.67e-04 | 407 | 70 | 6 | M19541 | |
| Coexpression | GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN | 7.77e-04 | 154 | 70 | 4 | M6824 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 8.05e-04 | 569 | 70 | 7 | M12701 | |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 8.07e-04 | 68 | 70 | 3 | M1406 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | BCL6B NID2 STAB2 FBN1 JAG1 LAMA4 LAMB1 LTBP1 LTBP2 CCL20 LTBP4 ADGRL4 | 1.60e-08 | 439 | 69 | 12 | GSM777059_500 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | STAB2 FBN1 CLEC14A JAG1 LAMA4 LAMB1 LTBP1 LTBP2 ACVR1 CCL20 LTBP4 ADGRL4 | 2.10e-08 | 450 | 69 | 12 | GSM777063_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | NID2 VLDLR FBN1 FBN2 NSD2 JAG1 LAMA4 LAMB1 LTBP1 LY6E CDH2 BANF1 PLSCR1 ST14 NOTCH1 | 2.46e-08 | 783 | 69 | 15 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 2.03e-06 | 455 | 69 | 10 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 2.20e-06 | 459 | 69 | 10 | GSM777037_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | ITGBL1 FBN1 SCARF2 CLEC14A ENPP1 LRP1 LAMA4 NTNG1 PAPPA LTBP1 LTBP2 ITGB1 ADGRL4 STC1 | 2.64e-06 | 981 | 69 | 14 | PCBC_ctl_BronchSmoothMuscl_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | BCL6B NID2 STAB2 CLEC14A JAG1 LAMA4 LAMB1 ALDH1B1 LTBP4 INSYN2A NOTCH1 ADGRL4 STC1 | 2.85e-06 | 846 | 69 | 13 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | VLDLR FBN2 MEGF6 SHISA2 LTBP1 PLSCR2 LY6E CDH2 PLSCR1 FBN3 STC1 | 4.37e-06 | 615 | 69 | 11 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 8.65e-06 | 148 | 69 | 6 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500 | 1.02e-05 | 430 | 69 | 9 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.34e-05 | 445 | 69 | 9 | GSM777043_500 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | VLDLR LRP12 FBN2 MEGF6 LAMB1 SHISA2 LTBP1 LTBP2 PLSCR2 LY6E CDH2 PLSCR1 STC1 | 1.42e-05 | 982 | 69 | 13 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | NID2 LRP12 FBN1 FBN2 MEGF6 JAG1 WNT8B LAMB1 SHISA2 LTBP1 LTBP2 ALDH2 ZFC3H1 CDH2 LTBP4 FBN3 | 1.42e-05 | 1466 | 69 | 16 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.60e-05 | 97 | 69 | 5 | GSM777043_100 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.61e-05 | 165 | 69 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | BCL6B NID2 STAB2 CLEC14A JAG1 LAMA4 LAMB1 BIRC3 INSYN2A NOTCH1 ADGRL4 STC1 | 1.63e-05 | 847 | 69 | 12 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | VLDLR LRP12 FBN2 MEGF6 SCARF2 LAMB1 SHISA2 LTBP1 PLSCR2 LY6E CDH2 PLSCR1 FBN3 STC1 | 1.67e-05 | 1153 | 69 | 14 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.20e-05 | 261 | 69 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | NID2 LAMB1 PAPPA LTBP2 ACVR1 TNFRSF1A CCL20 LY6E ITGB1 PLSCR1 ST14 | 3.19e-05 | 761 | 69 | 11 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | FBN1 FBN2 JAG1 LRP1 NTNG1 LAMB1 PAPPA ACVR1 ALDH1B1 LTBP4 STC1 | 3.68e-05 | 773 | 69 | 11 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 4.15e-05 | 395 | 69 | 8 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 4.38e-05 | 398 | 69 | 8 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | FBN1 FBN2 LRIG1 SBSPON ENPP1 NTNG1 PAPPA SHISA2 ACVR1 CDH2 STC1 | 4.54e-05 | 791 | 69 | 11 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_500 | 4.83e-05 | 122 | 69 | 5 | gudmap_developingGonad_P2_epididymis_500_k5 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.60e-05 | 64 | 69 | 4 | gudmap_kidney_e15.5_Podocyte_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500 | 5.77e-05 | 414 | 69 | 8 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 5.95e-05 | 65 | 69 | 4 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | NID2 ITGBL1 FBN1 SCARF2 CLEC14A LRP1 LAMA4 PAPPA LTBP2 ITGB1 ADGRL4 STC1 | 6.44e-05 | 975 | 69 | 12 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | BCL6B NID2 NTNG2 STAB2 FBN1 LAMA4 PAPPA LTBP1 PRKCQ TNFRSF1A LTBP4 MEGF11 ADGRL4 | 6.88e-05 | 1143 | 69 | 13 | gudmap_RNAseq_e15.5_Podocytes_2500_K0 |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000 | BCL6B CLEC14A LAMA4 PRKCQ PLSCR2 TNFRSF1A LY6E PLSCR1 INSYN2A NOTCH1 ADGRL4 | 8.65e-05 | 850 | 69 | 11 | gudmap_kidney_adult_RenMedVasc_Tie2_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.09e-04 | 336 | 69 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.13e-04 | 234 | 69 | 6 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 1.13e-04 | 456 | 69 | 8 | GSM777032_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.27e-04 | 464 | 69 | 8 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | placenta | 1.37e-04 | 349 | 69 | 7 | placenta | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | 1.45e-04 | 749 | 69 | 10 | gudmap_kidney_P3_CapMes_Crym_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 1.48e-04 | 82 | 69 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_200 | 1.54e-04 | 156 | 69 | 5 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.54e-04 | 156 | 69 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.55e-04 | 356 | 69 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_100 | 1.62e-04 | 84 | 69 | 4 | gudmap_kidney_adult_RenMedVasc_Tie2_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_100 | 1.62e-04 | 84 | 69 | 4 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_200 | 1.64e-04 | 158 | 69 | 5 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_200 | 1.69e-04 | 159 | 69 | 5 | gudmap_developingKidney_e15.5_Endothelial cells_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#4_top-relative-expression-ranked_200 | 1.77e-04 | 86 | 69 | 4 | gudmap_developingKidney_e15.5_Endothelial cells_200_k4 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_500 | 1.82e-04 | 489 | 69 | 8 | PCBC_ctl_BronchSmoothMuscl_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_500 | 1.93e-04 | 493 | 69 | 8 | PCBC_ctl_CardiacMyocyte_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.95e-04 | 164 | 69 | 5 | gudmap_developingKidney_e13.5_podocyte cells_1000_k5 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 1.97e-04 | 370 | 69 | 7 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Mesoderm Day 15-Confounder_removed-fold2.0_adjp0.05 | VLDLR LRP12 LRIG1 GRK6 SHISA2 PRKCQ PLSCR2 ALDH1B1 CDH2 BANF1 PLSCR1 FBN3 STC1 | 2.07e-04 | 1276 | 69 | 13 | PCBC_ratio_MESO-5_vs_MESO-15_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.18e-04 | 168 | 69 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 2.21e-04 | 91 | 69 | 4 | GSM777059_100 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.31e-04 | 267 | 69 | 6 | gudmap_developingKidney_e12.5_renal vesicle_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 2.40e-04 | 797 | 69 | 10 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | 2.40e-04 | 797 | 69 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | VLDLR ITGBL1 MEGF6 UBE3A ENPP1 LRP1 LTBP2 PLSCR2 LTBP4 BANF1 | 2.45e-04 | 799 | 69 | 10 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 2.50e-04 | 801 | 69 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 2.63e-04 | 175 | 69 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#2_top-relative-expression-ranked_500 | 2.82e-04 | 97 | 69 | 4 | gudmap_developingKidney_e13.5_podocyte cells_500_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_200 | 2.92e-04 | 179 | 69 | 5 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 2.96e-04 | 818 | 69 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_100 | 2.98e-04 | 40 | 69 | 3 | gudmap_kidney_adult_RenMedVasc_Tie2_k4_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | 2.99e-04 | 819 | 69 | 10 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_200 | 3.00e-04 | 180 | 69 | 5 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 3.09e-04 | 282 | 69 | 6 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k4_500 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.10e-04 | 529 | 69 | 8 | ratio_DE_vs_SC_1000_K5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_200 | 3.16e-04 | 182 | 69 | 5 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | BCL6B NID2 STAB2 CLEC14A LAMA4 LAMB1 ALDH1B1 INSYN2A NOTCH1 ADGRL4 | 3.35e-04 | 831 | 69 | 10 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.46e-04 | 288 | 69 | 6 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 3.56e-04 | 408 | 69 | 7 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_500 | 3.69e-04 | 43 | 69 | 3 | gudmap_kidney_e13.5_Podocyte_MafB_k1_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_500 | 3.72e-04 | 411 | 69 | 7 | gudmap_developingKidney_e12.5_renal vesicle_500 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#1 | 3.86e-04 | 294 | 69 | 6 | ratio_MESO_vs_SC_500_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_500 | 3.94e-04 | 415 | 69 | 7 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.94e-04 | 191 | 69 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_500 | 3.99e-04 | 416 | 69 | 7 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 4.15e-04 | 298 | 69 | 6 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_500 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#1_top-relative-expression-ranked_200 | 4.23e-04 | 45 | 69 | 3 | gudmap_kidney_adult_Mesangium_Meis_k1_200 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2 | 4.23e-04 | 420 | 69 | 7 | GSM791141_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | 4.29e-04 | 421 | 69 | 7 | gudmap_developingKidney_e15.5_Peripheral blastema_500 | |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 4.60e-04 | 10 | 69 | 2 | gudmap_kidney_e13.5_Podocyte_MafB_k4_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.09e-04 | 570 | 69 | 8 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.11e-04 | 310 | 69 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 5.36e-04 | 437 | 69 | 7 | GSM777046_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 5.56e-04 | 116 | 69 | 4 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k3_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 5.68e-04 | 207 | 69 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 6.04e-04 | 320 | 69 | 6 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | VLDLR FBN1 JAG1 GNPTAB NTNG1 LTBP1 PLSCR2 ITGB1 ADGRL4 SORL1 | 6.53e-04 | 905 | 69 | 10 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 6.63e-04 | 453 | 69 | 7 | GSM777067_500 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_k-means-cluster#1_top-relative-expression-ranked_500 | 6.73e-04 | 12 | 69 | 2 | gudmap_kidney_adult_RenalCortexMixed_Std_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_200 | 6.93e-04 | 123 | 69 | 4 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k2_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#4_top-relative-expression-ranked_500 | 7.03e-04 | 217 | 69 | 5 | gudmap_developingKidney_e15.5_Endothelial cells_500_k4 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 7.33e-04 | 219 | 69 | 5 | JC_hmvEC_500_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.36e-04 | 125 | 69 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.48e-04 | 220 | 69 | 5 | gudmap_kidney_adult_RenMedVasc_Tie2_k4_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 7.82e-04 | 466 | 69 | 7 | GSM777050_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 8.22e-04 | 768 | 69 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_k-means-cluster#3_top-relative-expression-ranked_500 | 8.44e-04 | 226 | 69 | 5 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_k3_500 | |
| CoexpressionAtlas | MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05 | DIPK1C VLDLR LRP12 FBN2 LRIG1 JAG1 SHISA2 LTBP1 ZFC3H1 ALDH1B1 LTBP4 FBN3 SORL1 | 8.48e-04 | 1479 | 69 | 13 | PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | 8.52e-04 | 772 | 69 | 9 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-11 | 200 | 70 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.91e-11 | 200 | 70 | 9 | ca777a7d001848f6d01c613ff2bda7e4f3e20521 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-11 | 200 | 70 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.98e-11 | 129 | 70 | 8 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.13e-10 | 173 | 70 | 8 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.56e-10 | 186 | 70 | 8 | a906020a8df6fcca474b278f746c553b177a56b4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.05e-10 | 188 | 70 | 8 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-10 | 190 | 70 | 8 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.86e-10 | 191 | 70 | 8 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-10 | 193 | 70 | 8 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.45e-10 | 193 | 70 | 8 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.76e-10 | 194 | 70 | 8 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.76e-10 | 194 | 70 | 8 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.09e-10 | 195 | 70 | 8 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-10 | 196 | 70 | 8 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-10 | 196 | 70 | 8 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.42e-10 | 196 | 70 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.77e-10 | 197 | 70 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.77e-10 | 197 | 70 | 8 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.77e-10 | 197 | 70 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.77e-10 | 197 | 70 | 8 | 9244f087ba4b60fdc81d54ce91860de715b3e12c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.12e-10 | 198 | 70 | 8 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 9.12e-10 | 198 | 70 | 8 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.12e-10 | 198 | 70 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.12e-10 | 198 | 70 | 8 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.12e-10 | 198 | 70 | 8 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.49e-10 | 199 | 70 | 8 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.49e-10 | 199 | 70 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.49e-10 | 199 | 70 | 8 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.49e-10 | 199 | 70 | 8 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.88e-10 | 200 | 70 | 8 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.88e-10 | 200 | 70 | 8 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-10 | 200 | 70 | 8 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.88e-10 | 200 | 70 | 8 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-10 | 200 | 70 | 8 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-10 | 200 | 70 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-10 | 200 | 70 | 8 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-10 | 200 | 70 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-10 | 200 | 70 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-08 | 175 | 70 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-08 | 175 | 70 | 7 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-08 | 180 | 70 | 7 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-08 | 181 | 70 | 7 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-08 | 181 | 70 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-08 | 181 | 70 | 7 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-08 | 183 | 70 | 7 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 1.65e-08 | 184 | 70 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-08 | 185 | 70 | 7 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.91e-08 | 188 | 70 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.98e-08 | 189 | 70 | 7 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.05e-08 | 190 | 70 | 7 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-08 | 190 | 70 | 7 | eae5bcdb8a35f3fba4d25854c1a43f83f80832a2 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-08 | 190 | 70 | 7 | d87b9e9ca863270a9c7f61674271a6440c97d1f4 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-08 | 190 | 70 | 7 | 3346bfd0474828b3729cffa9f4cc57b04dd30443 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.05e-08 | 190 | 70 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-08 | 191 | 70 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.13e-08 | 191 | 70 | 7 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.13e-08 | 191 | 70 | 7 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | facs-Lung-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.13e-08 | 191 | 70 | 7 | ba02cbdfda6a94374a6472eb88499059979af472 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.13e-08 | 191 | 70 | 7 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-08 | 192 | 70 | 7 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-08 | 192 | 70 | 7 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-08 | 192 | 70 | 7 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-08 | 192 | 70 | 7 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-08 | 192 | 70 | 7 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.21e-08 | 192 | 70 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-08 | 192 | 70 | 7 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-08 | 192 | 70 | 7 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-08 | 192 | 70 | 7 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-08 | 192 | 70 | 7 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-08 | 192 | 70 | 7 | ff4b728a55c2550c806c47e9ae3d057c35df8464 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-08 | 192 | 70 | 7 | 2d3790bd80a7f214b37094121a2a86ff16362569 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-08 | 192 | 70 | 7 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-08 | 193 | 70 | 7 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-08 | 193 | 70 | 7 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.37e-08 | 194 | 70 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | facs-Kidney-nan-3m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-08 | 194 | 70 | 7 | 5fa2dfca32cca4abfda0af90b83f2b2a826f9b6e | |
| ToppCell | facs-Kidney-nan-3m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-08 | 194 | 70 | 7 | 04df35246287815bdd28adaf885bdb98cf49524e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-08 | 194 | 70 | 7 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-08 | 194 | 70 | 7 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-08 | 194 | 70 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | facs-Kidney-nan-3m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-08 | 194 | 70 | 7 | 90928d6c96c6304ae35dcc0275f7889de93da100 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-08 | 195 | 70 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-08 | 195 | 70 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-08 | 195 | 70 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-08 | 195 | 70 | 7 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.45e-08 | 195 | 70 | 7 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-08 | 196 | 70 | 7 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-08 | 196 | 70 | 7 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-08 | 196 | 70 | 7 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-08 | 196 | 70 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-08 | 196 | 70 | 7 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-08 | 196 | 70 | 7 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.63e-08 | 197 | 70 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.63e-08 | 197 | 70 | 7 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-08 | 197 | 70 | 7 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-08 | 197 | 70 | 7 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-08 | 197 | 70 | 7 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-08 | 197 | 70 | 7 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.63e-08 | 197 | 70 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| Computational | Metal / Ca ion binding. | 2.11e-06 | 133 | 49 | 7 | MODULE_324 | |
| Computational | Adhesion molecules. | 4.03e-05 | 141 | 49 | 6 | MODULE_122 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.52e-05 | 50 | 49 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_30_PDAC_CLASSICAL | |
| Drug | funiferine N-oxide | 4.08e-07 | 49 | 70 | 5 | CID000191631 | |
| Drug | monatepil | 1.84e-06 | 29 | 70 | 4 | CID000060810 | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A | 2.39e-06 | 196 | 70 | 7 | 3604_UP | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.64e-06 | 199 | 70 | 7 | 3410_DN | |
| Drug | bis(tri-n-butyltin)oxide | HDAC3 VLDLR FBN1 LAMA4 LAMB1 BIRC3 SHISA2 PRKCQ MUC13 TNFRSF1A | 5.55e-06 | 538 | 70 | 10 | ctd:C005961 |
| Drug | pyrachlostrobin | NID2 FBN1 PAPPA LTBP1 LTBP2 PLSCR2 TNFRSF1A ITGB1 CDH7 NOTCH1 EPHA10 SORL1 | 6.13e-06 | 811 | 70 | 12 | ctd:C513428 |
| Drug | mucic acid | 7.64e-06 | 88 | 70 | 5 | CID000000607 | |
| Drug | Vanadates | VLDLR ITGBL1 LRIG1 JAG1 GNPTAB LRP1 LAMB1 BIRC3 PAPPA SHISA2 LTBP1 LTBP2 ALDH2 PLSCR1 STC1 | 7.77e-06 | 1302 | 70 | 15 | ctd:D014638 |
| Drug | Betamethasone-d5 | SCARF2 ENPP1 LRP1 LAMA4 LAMB1 BIRC3 LTBP1 PRKCQ ACVR1 TNFRSF1A CCL20 ITGB1 MUC5AC FBN3 ADGRL4 | 1.10e-05 | 1340 | 70 | 15 | CID000003003 |
| Drug | MRK 003 | LRP12 NTNG2 LRIG1 LAMA4 LTBP2 PLSCR2 CDH2 MEGF11 ST14 INSYN2A NOTCH1 | 1.92e-05 | 760 | 70 | 11 | ctd:C523799 |
| Drug | 5-aza-2'-deoxycytidine | 2.43e-05 | 638 | 70 | 10 | CID000016886 | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 2.47e-05 | 188 | 70 | 6 | 5116_DN | |
| Drug | pitavastatin | 2.69e-05 | 114 | 70 | 5 | CID005282451 | |
| Drug | Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.04e-05 | 195 | 70 | 6 | 3669_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 3.04e-05 | 195 | 70 | 6 | 7504_UP | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; HL60; HG-U133A | 3.13e-05 | 196 | 70 | 6 | 1586_UP | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 2703_UP | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 6198_UP | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 6037_UP | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 2893_DN | |
| Drug | Altretamine [654-05-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 6467_UP | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 4280_UP | |
| Drug | Isocarboxazid [59-63-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 4706_UP | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 3544_UP | |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 3934_UP | |
| Drug | sodium cholate | 3.55e-05 | 408 | 70 | 8 | CID000000303 | |
| Drug | TAAD | 3.56e-05 | 21 | 70 | 3 | CID000133445 | |
| Drug | Diethylstilbestrol | NID2 VLDLR FCGBP FBN2 MEGF8 WNT7A JAG1 LAMA4 ALDH2 LY6E CDH2 LTBP4 NOTCH1 TFF2 | 3.62e-05 | 1305 | 70 | 14 | ctd:D004054 |
| Drug | troglitazone | NID2 VLDLR FBN1 CLEC14A LAMA4 BIRC3 PAPPA PLSCR2 ALDH2 MUC13 CCL20 LTBP4 ST14 STC1 | 4.42e-05 | 1329 | 70 | 14 | ctd:C057693 |
| Drug | Methylprednisolone | 4.87e-05 | 129 | 70 | 5 | ctd:D008775 | |
| Drug | aldophosphamide | 5.38e-05 | 24 | 70 | 3 | CID000107744 | |
| Drug | AC1L1EPA | 5.57e-05 | 4 | 70 | 2 | CID000028140 | |
| Drug | N,N-dibenzylphenylethanolamine | 5.57e-05 | 4 | 70 | 2 | CID000048896 | |
| Drug | Epi Lovastatin | 8.48e-05 | 341 | 70 | 7 | CID000003962 | |
| Drug | AC1L1J6H | 8.77e-05 | 236 | 70 | 6 | CID000004889 | |
| Drug | Rgd Peptide | 9.40e-05 | 239 | 70 | 6 | CID000104802 | |
| Drug | Dasatinib | 1.07e-04 | 478 | 70 | 8 | ctd:D000069439 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.16e-04 | 155 | 70 | 5 | 6817_DN | |
| Drug | Smoke | LAMA4 SHISA2 LTBP1 PRKCQ ALDH2 MUC13 TNFRSF1A CDH2 ST14 NOTCH1 SORL1 | 1.27e-04 | 937 | 70 | 11 | ctd:D012906 |
| Drug | AC1NAG0I | 1.29e-04 | 32 | 70 | 3 | CID004476319 | |
| Drug | NSC49080 | 1.42e-04 | 33 | 70 | 3 | CID000002192 | |
| Drug | probucol | 1.43e-04 | 162 | 70 | 5 | CID000004912 | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 1.48e-04 | 373 | 70 | 7 | ctd:C540355 | |
| Drug | 17alpha-estradiol | VLDLR LRP12 SCARF2 WNT7A JAG1 WNT8B LRP1 PAPPA PRKCQ CCL20 TFF2 ADGRL4 SORL1 | 1.49e-04 | 1303 | 70 | 13 | CID000000450 |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.69e-04 | 168 | 70 | 5 | 4671_UP | |
| Drug | mono-(2-ethylhexyl)phthalate | 1.80e-04 | 658 | 70 | 9 | ctd:C016599 | |
| Drug | PNP dimethylcarbamate | 1.94e-04 | 7 | 70 | 2 | CID000081656 | |
| Drug | 3-butynal | 1.94e-04 | 7 | 70 | 2 | CID000142966 | |
| Drug | N1-ethylchlorpropamide | 1.94e-04 | 7 | 70 | 2 | CID000362592 | |
| Drug | 3-butynoate | 1.94e-04 | 7 | 70 | 2 | CID000137547 | |
| Drug | p-dioxin | 2.01e-04 | 37 | 70 | 3 | CID000078968 | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; HL60; HT_HG-U133A | 2.05e-04 | 175 | 70 | 5 | 2507_UP | |
| Drug | ethylphenyl(2-formylethyl)phosphinate | 2.58e-04 | 8 | 70 | 2 | CID000151185 | |
| Drug | nitrefazole | 2.58e-04 | 8 | 70 | 2 | CID000071900 | |
| Drug | AC1L8X1L | 2.58e-04 | 8 | 70 | 2 | CID000409504 | |
| Drug | C04554 | 2.58e-04 | 8 | 70 | 2 | CID000440384 | |
| Drug | 1-Methyl-3-isobutylxanthine | 2.79e-04 | 414 | 70 | 7 | ctd:D015056 | |
| Drug | Niclosamide | 3.07e-04 | 191 | 70 | 5 | ctd:D009534 | |
| Drug | Benzamil hydrochloride [2898-76-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 3635_UP | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.22e-04 | 193 | 70 | 5 | 3347_UP | |
| Drug | pioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A | 3.22e-04 | 193 | 70 | 5 | 6893_UP | |
| Drug | CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 6417_DN | |
| Drug | semustine; Down 200; 100uM; PC3; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 7545_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 3.30e-04 | 194 | 70 | 5 | 1060_UP | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; PC3; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 1823_UP | |
| Drug | 4-acetamidobutyrate | 3.31e-04 | 9 | 70 | 2 | CID000018189 | |
| Drug | L 574 | 3.31e-04 | 9 | 70 | 2 | CID000067114 | |
| Drug | CPD 30 | 3.31e-04 | 9 | 70 | 2 | CID000440850 | |
| Drug | CS-0398 | 3.37e-04 | 44 | 70 | 3 | CID005288149 | |
| Drug | ovothiol A | 3.37e-04 | 44 | 70 | 3 | CID000130131 | |
| Drug | N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | 3.37e-04 | 44 | 70 | 3 | ctd:C419410 | |
| Drug | Gossypol [303-45-7]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 6058_UP | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 2270_UP | |
| Drug | Chlormezanone [80-77-3]; Down 200; 14.6uM; HL60; HG-U133A | 3.45e-04 | 196 | 70 | 5 | 1620_DN | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 10uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 3690_UP | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 3923_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; HL60; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 3006_UP | |
| Drug | Isosorbide dinitrate [87-33-2]; Up 200; 17uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 3720_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 4288_UP | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; PC3; HG-U133A | 3.45e-04 | 196 | 70 | 5 | 1921_DN | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 7513_DN | |
| Drug | U0126 | 3.51e-04 | 430 | 70 | 7 | CID000005637 | |
| Drug | Cinnarizine [298-57-7]; Up 200; 10.8uM; HL60; HG-U133A | 3.54e-04 | 197 | 70 | 5 | 1558_UP | |
| Drug | Pyrazinamide [ 98-96-4]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 2839_UP | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 7533_DN | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 5541_UP | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; PC3; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 6700_DN | |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; PC3; HT_HG-U133A | 3.54e-04 | 197 | 70 | 5 | 5069_UP | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 4414_UP | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 2281_UP | |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; PC3; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 5799_DN | |
| Drug | Flufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 5059_DN | |
| Drug | Glibenclamide [10238-21-8]; Down 200; 8uM; PC3; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 5849_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.62e-04 | 198 | 70 | 5 | 5635_UP | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; PC3; HT_HG-U133A | 3.70e-04 | 199 | 70 | 5 | 4277_UP | |
| Drug | Tiletamine hydrochloride; Up 200; 15.4uM; HL60; HT_HG-U133A | 3.70e-04 | 199 | 70 | 5 | 3137_UP | |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; HL60; HT_HG-U133A | 3.70e-04 | 199 | 70 | 5 | 2400_DN | |
| Drug | Suramin sodium salt; Down 200; 10uM; MCF7; HT_HG-U133A | 3.70e-04 | 199 | 70 | 5 | 7524_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.70e-04 | 199 | 70 | 5 | 997_DN | |
| Drug | PF-00875133-00 [351322-64-0]; Up 200; 10uM; PC3; HT_HG-U133A | 3.70e-04 | 199 | 70 | 5 | 5928_UP | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.28e-08 | 3 | 70 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | FEV/FEC ratio | NID2 FBN1 FCGBP MEGF6 SCARF2 SBSPON WNT7A LRP1 LTBP1 LTBP2 ACVR1 LTBP4 SORL1 | 5.50e-06 | 1228 | 70 | 13 | EFO_0004713 |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 7.79e-06 | 53 | 70 | 4 | C4707243 | |
| Disease | Liver Cirrhosis, Experimental | NID2 FBN1 BIRC3 LTBP1 PLSCR2 ALDH2 ALDH1B1 ITGB1 PLSCR1 ST14 | 1.39e-05 | 774 | 70 | 10 | C0023893 |
| Disease | glomerulonephritis (biomarker_via_orthology) | 1.42e-05 | 20 | 70 | 3 | DOID:2921 (biomarker_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 1.66e-05 | 3 | 70 | 2 | C0265313 | |
| Disease | netrin-G1 measurement | 1.66e-05 | 3 | 70 | 2 | EFO_0801825 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 1.66e-05 | 3 | 70 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 1.66e-05 | 3 | 70 | 2 | C1869114 | |
| Disease | scoliosis (is_implicated_in) | 3.32e-05 | 4 | 70 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome | 3.32e-05 | 4 | 70 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 3.32e-05 | 4 | 70 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | Endometrioma | 4.13e-05 | 161 | 70 | 5 | C0269102 | |
| Disease | Endometriosis | 4.13e-05 | 161 | 70 | 5 | C0014175 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 5.20e-05 | 169 | 70 | 5 | DOID:3908 (is_marker_for) | |
| Disease | pulse pressure measurement, migraine without aura, susceptibility to, 4 | 1.98e-04 | 9 | 70 | 2 | EFO_0005763, MONDO_0011847 | |
| Disease | cranial vault morphology measurement | 2.00e-04 | 121 | 70 | 4 | EFO_0009278 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 2.31e-04 | 50 | 70 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | aortic aneurysm | 2.47e-04 | 10 | 70 | 2 | EFO_0001666 | |
| Disease | response to bisphosphonate, osteonecrosis | 2.47e-04 | 10 | 70 | 2 | EFO_0004259, EFO_0009958 | |
| Disease | Alzheimer's disease (is_implicated_in) | 2.79e-04 | 132 | 70 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | pulmonary fibrosis | 3.01e-04 | 11 | 70 | 2 | EFO_0009448 | |
| Disease | Marfan Syndrome | 3.01e-04 | 11 | 70 | 2 | C0024796 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.40e-04 | 139 | 70 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Connective Tissue Diseases | 4.25e-04 | 13 | 70 | 2 | C0009782 | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.80e-04 | 64 | 70 | 3 | DOID:4947 (is_marker_for) | |
| Disease | uric acid measurement | 6.06e-04 | 610 | 70 | 7 | EFO_0004761 | |
| Disease | anorexia nervosa | 6.25e-04 | 70 | 70 | 3 | MONDO_0005351 | |
| Disease | Non-alcoholic Fatty Liver Disease | 6.25e-04 | 70 | 70 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 6.25e-04 | 70 | 70 | 3 | C3241937 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 6.52e-04 | 16 | 70 | 2 | C0334634 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 7.52e-04 | 301 | 70 | 5 | DOID:684 (is_marker_for) | |
| Disease | Glioblastoma | 8.89e-04 | 79 | 70 | 3 | C0017636 | |
| Disease | Malignant neoplasm of breast | 9.61e-04 | 1074 | 70 | 9 | C0006142 | |
| Disease | IgA glomerulonephritis (is_marker_for) | 1.03e-03 | 20 | 70 | 2 | DOID:2986 (is_marker_for) | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.05e-03 | 670 | 70 | 7 | EFO_0006335, EFO_0006336 | |
| Disease | Giant Cell Glioblastoma | 1.06e-03 | 84 | 70 | 3 | C0334588 | |
| Disease | Infiltrating duct carcinoma of female breast | 1.13e-03 | 21 | 70 | 2 | C3165106 | |
| Disease | Schizophrenia | 1.14e-03 | 883 | 70 | 8 | C0036341 | |
| Disease | peak expiratory flow | 1.18e-03 | 498 | 70 | 6 | EFO_0009718 | |
| Disease | descending aortic diameter | 1.21e-03 | 88 | 70 | 3 | EFO_0021788 | |
| Disease | cortical surface area measurement | 1.23e-03 | 1345 | 70 | 10 | EFO_0010736 | |
| Disease | Acute Lung Injury | 1.24e-03 | 22 | 70 | 2 | C0242488 | |
| Disease | Colorectal Carcinoma | 1.37e-03 | 702 | 70 | 7 | C0009402 | |
| Disease | congenital heart disease (is_implicated_in) | 1.48e-03 | 24 | 70 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | aspartate measurement | 1.48e-03 | 24 | 70 | 2 | EFO_0010462 | |
| Disease | Carcinoma, Pancreatic Ductal | 1.48e-03 | 24 | 70 | 2 | C0887833 | |
| Disease | Mammary Carcinoma, Human | 1.54e-03 | 525 | 70 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.54e-03 | 525 | 70 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 1.57e-03 | 527 | 70 | 6 | C1458155 | |
| Disease | Postural instability | 1.61e-03 | 25 | 70 | 2 | HP_0002172 | |
| Disease | Cerebral Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0750936 | |
| Disease | Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0004114 | |
| Disease | Grade I Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.61e-03 | 25 | 70 | 2 | C0547065 | |
| Disease | corpus collosum mid-posterior volume measurement | 1.61e-03 | 25 | 70 | 2 | EFO_0010300 | |
| Disease | Pilocytic Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0338070 | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 1.61e-03 | 97 | 70 | 3 | DOID:3083 (is_marker_for) | |
| Disease | susceptibility to pneumonia measurement | 1.61e-03 | 97 | 70 | 3 | EFO_0008410 | |
| Disease | myocardial infarction (is_implicated_in) | 1.70e-03 | 99 | 70 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | Gemistocytic astrocytoma | 1.74e-03 | 26 | 70 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.74e-03 | 26 | 70 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.74e-03 | 26 | 70 | 2 | C0334582 | |
| Disease | Breast Carcinoma | 1.75e-03 | 538 | 70 | 6 | C0678222 | |
| Disease | pancreatic cancer (is_marker_for) | 1.80e-03 | 101 | 70 | 3 | DOID:1793 (is_marker_for) | |
| Disease | Anaplastic astrocytoma | 1.87e-03 | 27 | 70 | 2 | C0334579 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 2.02e-03 | 28 | 70 | 2 | DOID:1094 (implicated_via_orthology) | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment | 2.02e-03 | 105 | 70 | 3 | EFO_0007788, EFO_0008007, EFO_0008343 | |
| Disease | pulmonary tuberculosis | 2.16e-03 | 29 | 70 | 2 | EFO_1000049 | |
| Disease | Glioblastoma Multiforme | 2.36e-03 | 111 | 70 | 3 | C1621958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CEDDNECGNLTQSCG | 56 | Q9HBW9 | |
| GQCCCAGSRTFVEES | 316 | P30837 | |
| SCGNEDHCEGQQCFS | 41 | Q04771 | |
| NSDDVKCFCCDGGLR | 286 | Q13489 | |
| CVNGVCLNEDGSFSC | 541 | Q75N90 | |
| DECAQGNLCAFGSCE | 1406 | Q75N90 | |
| GRCVNTAGSFRCDCD | 2266 | Q75N90 | |
| NDACACDSGGDCECF | 1111 | Q9HC84 | |
| GQDTANCDTCRNSAC | 401 | Q6ZSG2 | |
| NGTFECGACRCNEGR | 481 | P05556 | |
| KFCECDNFNCDRSNG | 551 | P05556 | |
| GLNCNESCTCANGAA | 486 | A6BM72 | |
| NFDCGSCQSCQGEAV | 11 | Q04759 | |
| SDGHCDSQCNSAGCL | 1501 | P46531 | |
| DSQCNSAGCLFDGFD | 1506 | P46531 | |
| SDGHCDQGCNSAECE | 1541 | P46531 | |
| SEEPNCACDQFRCGN | 161 | Q9Y561 | |
| SCDEGNAASSRCLDC | 201 | Q2Q1W2 | |
| CAAACTCAGDSLDCG | 41 | Q96JA1 | |
| QACNVLSCGFDAGDC | 521 | Q3T906 | |
| ALLCNGQDDCGDSSD | 2921 | Q07954 | |
| CTNPAFICDGDNDCQ | 3386 | Q07954 | |
| GCQDINECLRFGTCS | 3821 | Q07954 | |
| FAAEDTDCCTRNCCG | 141 | O15162 | |
| AEDTNFCIRNCCGRS | 131 | Q9NRY7 | |
| CSQGRCENTEGSFLC | 926 | Q14766 | |
| CRCGASNCSGFLGDR | 1191 | O96028 | |
| RGHCDNLSGLCFCQD | 1221 | Q7Z7M0 | |
| DCDLGGALNNSCFAE | 511 | P07942 | |
| TFGNCRCDAACVELG | 116 | P22413 | |
| CDGTNNCGDCSDELS | 141 | Q5T700 | |
| NDACACDSGGDCECF | 1121 | P98088 | |
| CSAGFQERGDFCEAC | 271 | Q5JZY3 | |
| NNRAFCNYDGGDCCT | 1571 | Q13219 | |
| CGADSLGCDRLGCFN | 256 | O15379 | |
| CECASGYQGDGRNCV | 786 | Q14112 | |
| FSCQNCEAVAGCSSG | 301 | Q8N143 | |
| GCQCDAGFVLSADRC | 1986 | Q9Y6R7 | |
| DECSENLNLCGNGQC | 1406 | P35555 | |
| DINECERDACGNGTC | 1891 | P35555 | |
| CLNTEGSFACSACEN | 1066 | Q14767 | |
| HGFCDNTDGSFRCLC | 1316 | Q14767 | |
| SCCQSFLCNFSAADG | 91 | Q16553 | |
| GCQDVDECRNRSFCG | 1046 | Q8N2S1 | |
| RVCDCDADGVAQTCN | 581 | Q9ULB5 | |
| ECSSFFGQVCRNGRC | 1976 | P35556 | |
| FSRQDCCGNCSDSEE | 556 | P43250 | |
| TCGANAKQSRDCFGC | 66 | O75531 | |
| DFCSGHGQCNCGRCD | 286 | O95965 | |
| CQCDSNGDCTDVDRI | 701 | P19022 | |
| TGDEDCNFFDCFSRC | 316 | Q0P6D2 | |
| PCDCNGNSNECLDGS | 81 | Q16363 | |
| DSQCDEATCNNGGTC | 706 | P78504 | |
| FGHDCSLTCDDCRNG | 516 | O75095 | |
| FFGLDCRSACNCTAG | 951 | O75095 | |
| NCTAGAACDAVNGSC | 961 | O75095 | |
| GSIHDRCNGSGFCEC | 426 | Q9Y2I2 | |
| CDDDQLLCQNGGTCL | 456 | Q96CW9 | |
| QCRDGSDEDAAFAGC | 1301 | Q92673 | |
| CSSAEARLDQGGCDN | 76 | Q6UWI4 | |
| QVGCGAFACLENSTC | 51 | P52823 | |
| GQCCCAGSRTFVQED | 316 | P05091 | |
| CGESEAASNFDCCLG | 21 | P78556 | |
| NCLDDLGGFACECAT | 261 | Q86T13 | |
| CDCLNGGSCVSDRNF | 1181 | Q8N2E2 | |
| TRNCSLGDFDNCGCD | 101 | Q93098 | |
| LGDFDNCGCDDSRNG | 106 | Q93098 | |
| TEGCGNEACTNEFCA | 41 | Q05086 | |
| CNQTADDCLNGLACD | 331 | Q9H3R2 | |
| FCDQACRFTGDCCFD | 51 | Q8IVN8 | |
| SECLRACGAEVGCSN | 336 | A0PJK1 | |
| NSRFTDCCLCVAGQE | 196 | O43791 | |
| CADCGSGHCDFQSGR | 376 | Q96GP6 | |
| VNDCGDNSDEQGCSC | 511 | Q9Y5Y6 | |
| GITSDQCFDNGCCFD | 46 | Q03403 | |
| QCFDNGCCFDSSVTG | 51 | Q03403 | |
| CEEGFQGSQCQFCSD | 766 | Q8WWQ8 | |
| AACTQGNLSDCGCDK | 121 | O00755 | |
| EDGAQQCLDCGLCFA | 1131 | Q8N1G0 | |
| GFFLRENECVSCSNC | 171 | P19438 | |
| CRFDLTGTCNDDDCQ | 1186 | O60293 | |
| GQCREQGATFTCECE | 2721 | Q9Y493 | |
| CISRNFVCNGQDDCS | 166 | P98155 |